{"content":"<li class=\"n-box-item date-title\" data-end=\"1544504399\" data-start=\"1544418000\" data-txt=\"Monday, December 23, 2019\">Monday, December 10, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3415866\" data-ts=\"1544485740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYR\" target=\"_blank\">AYR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415866-aircastleminus-4-seeks-to-repossess-11-avianca-brazil-aircraft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aircastle -4% as it seeks to repossess 11 Avianca Brazil aircraft</a></h4><ul><li>Aircastle (NYSE:<a href='https://seekingalpha.com/symbol/AYR' title='Aircastle Limited'>AYR</a>) <font color=\"red\">-3.7%</font> after-hours on news it <a href=\"https://www.sec.gov/Archives/edgar/data/1362988/000136298818000133/form8-kdecember2018.htm\" target=\"_blank\">terminated the leases</a> for and began the process to repossess 11 Airbus aircraft that had been on lease to Avianca Brazil (NYSE:<a href='https://seekingalpha.com/symbol/AVH' title='Avianca Holdings SA'>AVH</a>) because of a delinquent receivables problem with the airline.</li><li>AYR says it is already in remarketing discussions with several potential customers.</li><li>As a result of the terminations, AYR lowers its Q4 lease rental revenue guidance to $182M-$184M from $187M-$191M previously.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415866\" data-linked=\"Aircastle -4% as it seeks to repossess 11 Avianca Brazil aircraft\" data-tweet=\"$AYR $AYR $AVH - Aircastle -4% as it seeks to repossess 11 Avianca Brazil aircraft https://seekingalpha.com/news/3415866-aircastleminus-4-seeks-to-repossess-11-avianca-brazil-aircraft?source=tweet\" data-url=\"https://seekingalpha.com/news/3415866-aircastleminus-4-seeks-to-repossess-11-avianca-brazil-aircraft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415861\" data-ts=\"1544483933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415861-cars-com-told-to-improve-performance-shareholder-starboard\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com told to improve performance by shareholder Starboard</a></h4><ul><li>Cars.com (NYSE:<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a>) <font color=\"green\">+1.5%</font> after-hours as activist shareholder Starboard Value, which owns slightly less than 10% of the company, says the board should <a href=\"https://seekingalpha.com/pr/17353686-starboard-delivers-letter-cars-com-board-directors\" target=\"_blank\">set financial targets</a> that reflect the true earnings potential of the company as well as a plan to achieve the targets.</li><li>The hedge fund says CARS has suffered a continuous trend of customer losses and revenue declines amid higher operating expenses, resulting in a pattern of missing expectations and cutting guidance.</li><li>Starboard says CARS should generate ~$4/share of adjusted free cash flow by the end of 2020 if the company was properly managed.</li><li>Starboard says the company should take more substantive actions if shareholders do not see progress soon, including potential management changes and a potential sale of the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415861\" data-linked=\"Cars.com told to improve performance by shareholder Starboard\" data-tweet=\"$CARS - Cars.com told to improve performance by shareholder Starboard https://seekingalpha.com/news/3415861-cars-com-told-to-improve-performance-shareholder-starboard?source=tweet\" data-url=\"https://seekingalpha.com/news/3415861-cars-com-told-to-improve-performance-shareholder-starboard\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415854\" data-ts=\"1544482123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAMP\" target=\"_blank\">CAMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415854-calampminus-9_6-supply-issues-force-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CalAmp -9.6% as supply issues force guidance cut</a></h4><ul>   <li>CalAmp (NASDAQ:<a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a>) is <font color=\"red\">9.6% lower</font> after it <a href=\"https://seekingalpha.com/pr/17353661-calamp-updates-fiscal-2019-third-quarter-financial-outlook\" target=\"_blank\">trimmed its Q3 forecast</a> based on supply chain issues.</li>    <li>The company had discussed accelerated supply chain diversification on Sept. 27, against a backdrop of escalated trade tensions with China.</li>    <li>\"During the third quarter, CalAmp experienced various supply disruptions related to this transition, as well as extended lead times driven by component shortages,\" the company says. \"This resulted in inbound product supply delays at quarter end and impacted the Company's ability to ship certain products to meet customer demand.\"</li>    <li>It's now guiding to GAAP revenues of $88M-$89M and EPS of -$0.03 to -$0.01; on a non-GAAP basis, it's forecasting EBITDA of $10.5M-$11.5M and EPS of $0.23-$0.25 (below consensus for $0.32).</li>    <li>It's got a call set to discuss Q3 results and Q4 outlook for 4:30 p.m. ET on Dec. 20.</li>    <li>The company also says its board has authorized a <a href=\"https://seekingalpha.com/pr/17353720-calamp-announces-stock-repurchase-program\" target=\"_blank\">stock repurchase program of $20M</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415854\" data-linked=\"CalAmp -9.6% as supply issues force guidance cut\" data-tweet=\"$CAMP - CalAmp -9.6% as supply issues force guidance cut https://seekingalpha.com/news/3415854-calampminus-9_6-supply-issues-force-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3415854-calampminus-9_6-supply-issues-force-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415852\" data-ts=\"1544481402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415852-asna-casy-sfix-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ASNA, CASY &amp; SFIX among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color=\"green\">+12.1%</font>. <a href='https://seekingalpha.com/symbol/RTIX' title='RTI Surgical, Inc.'>RTIX</a> <font color=\"green\">+3.8%</font>. <a href='https://seekingalpha.com/symbol/DFRG' title='Del Frisco&#39;s Restaurant Group'>DFRG</a> <font color=\"green\">+3.3%</font>. <a href='https://seekingalpha.com/symbol/ACA' title='Arcosa, Inc.'>ACA</a> <font color=\"green\">+3.3%</font>. <a href='https://seekingalpha.com/symbol/STAY' title='Extended Stay America, Inc.'>STAY</a> <font color=\"green\">+2.8%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color=\"red\">-12.4%</font>. <a href='https://seekingalpha.com/symbol/FRTA' title='Forterra'>FRTA</a> <font color=\"red\">-7.8%</font>. <a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a> <font color=\"red\">-7.6%</font>. <a href='https://seekingalpha.com/symbol/NX' title='Quanex Building Products Corporation'>NX</a> <font color=\"red\">-4.9%</font>. <a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a> <font color=\"red\">-3.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415852\" data-linked=\"ASNA, CASY &amp; SFIX among notable after hour movers\" data-tweet=\"$ASNA $ASNA $RTIX - ASNA, CASY &amp; SFIX among notable after hour movers https://seekingalpha.com/news/3415852-asna-casy-sfix-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415852-asna-casy-sfix-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415851\" data-ts=\"1544480544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415851-cbs-deal-to-sell-television-city-for-750m-sharesplus-2_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS has deal to sell Television City for $750M; shares +2.3%</a></h4><ul>   <li>After more than a year of floating the sale, <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> has a deal to <a href=\"https://seekingalpha.com/pr/17353682-cbs-corporation-announces-agreement-sell-cbs-television-city\" target=\"_blank\">sell its iconic Television City production studios</a> for $750M.</li>    <li>Hackman Capital Partners will take over the 25-acre property and sound stage along with the rights to use the Television City trademark.</li>    <li>Shares are <font color=\"green\">up 2.3%</font> after hours.</li>    <li>Last month, reports had <a href=\"https://seekingalpha.com/news/3397727-cbs-set-sell-venerable-studios-700m-deal\" target=\"_blank\">Hackman winning an auction</a> with a total that was expected to top $700M.</li>    <li>As expected, CBS has secured continuing rights to produce programs on the campus for at least five years. Among the series produced there are <i>The Late Late Show with James Corden, The Price is Right, The Young and the Restless</i> and <i>The Bold and the Beautiful.</i></li>    <li>Primary production for CBS TV will still be at the 40-acre CBS Studios Center in Studio City, Calif.</li>    <li>\"The sale of Television City unlocks significant value, increasing CBS' financial flexibility, including the ability to redeploy capital for strategic growth initiatives such as additional content investment,\" says interim CEO Joe Ianniello.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415851\" data-linked=\"CBS has deal to sell Television City for $750M; shares +2.3%\" data-tweet=\"$CBS $VIAC - CBS has deal to sell Television City for $750M; shares +2.3% https://seekingalpha.com/news/3415851-cbs-deal-to-sell-television-city-for-750m-sharesplus-2_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3415851-cbs-deal-to-sell-television-city-for-750m-sharesplus-2_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415849\" data-ts=\"1544480090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415849-stitch-fix-turns-down-14-after-low-side-ebitda-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix turns down 14% after low-side EBITDA forecast</a></h4><ul>   <li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) has turned lower after an initial <a href=\"https://seekingalpha.com/news/3415797-stitch-fix-plus-6-percent-strong-fq1-report\" target=\"_blank\">post-earnings pop</a>, now <font color=\"red\">down 14%</font>, after guiding low on Q2 underlying earnings.</li>    <li>On its conference call, the company's guiding to Q2 revenues of $360M-$368M (vs. consensus for $362.7M, and marking growth of 22-24%) and adjusted EBITDA of $8M-$12M, below consensus for $12.8M (and representing EBITDA margin of 2.2-3.3%).</li>    <li>For the full year, it sees net revenues of $1.49B-$1.53B (in line with consensus for $1.51B) and EBITDA of $20M-$40M vs. expectations for $34.8M.</li><li>It expects to spend less on advertising in Q2 vs. Q1.</li>    <li><a href=\"https://investors.stitchfix.com/system/files-encrypted/nasdaq_kms/assets/2018/10/01/19-52-24/2018.09.27%20SFIX%20Q4%20Presentation.pdf\" target=\"_blank\">Earnings call slides</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3415849\" data-linked=\"Stitch Fix turns down 14% after low-side EBITDA forecast\" data-tweet=\"$SFIX - Stitch Fix turns down 14% after low-side EBITDA forecast https://seekingalpha.com/news/3415849-stitch-fix-turns-down-14-after-low-side-ebitda-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3415849-stitch-fix-turns-down-14-after-low-side-ebitda-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415846\" data-ts=\"1544479647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRT\" target=\"_blank\">BRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415846-brt-apartmentsminus-1_0-after-q4-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BRT Apartments -1.0% after Q4 revenue miss</a></h4><ul><li>BRT Apartments (NYSE:<a href='https://seekingalpha.com/symbol/BRT' title='BRT Apartments Corp.'>BRT</a>) <font color=\"red\">slips 1.0%</font> after <a href=\"https://seekingalpha.com/pr/17353625-brt-apartments-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Q4 revenue</a> of $30.2M missed consensus estimate of $31.1M; compares with $26.9M a year ago.</li><li>Q4 adjusted FFO per share of 20 cents match consensus; compares with 19 cents a year ago.</li><li>\"We expect to benefit in 2019 from our value-add program and the demographic and economic tailwinds supporting rental housing,\" says President and CEO Jeffrey A. Gould.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415817-brt-apartments-ffo-line-misses-revenue\" target=\"_blank\">BRT Apartments FFO in-line, misses on revenue</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415846\" data-linked=\"BRT Apartments -1.0% after Q4 revenue miss\" data-tweet=\"$BRT - BRT Apartments -1.0% after Q4 revenue miss https://seekingalpha.com/news/3415846-brt-apartmentsminus-1_0-after-q4-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3415846-brt-apartmentsminus-1_0-after-q4-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415839\" data-ts=\"1544479187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415839-guggenheim-starts-okta-buy-calls-best-idea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guggenheim starts Okta at Buy, calls Best Idea</a></h4><ul><li>Guggenheim <a href=\"https://www.streetinsider.com/Hot+New+Coverage/Guggenheim+Starts+Okta%2C+Inc+%28OKTA%29+at+Buy%2C+Added+to+Best+Idea+List/14908021.html\" target=\"_blank\">starts</a> Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) at Buy with a $79 price target and adds the company to its Best Idea list.</li><li>Last week, Okta reported Q3 results with upside guidance.</li><li>Okta shares are <font color=\"green\">up 1%</font> aftermarket to $65.20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3414727-okta-reports-q3-beats-upside-guidance\" target=\"_blank\">Okta reports Q3 beats, upside guidance</a> (Dec. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415839\" data-linked=\"Guggenheim starts Okta at Buy, calls Best Idea\" data-tweet=\"$OKTA - Guggenheim starts Okta at Buy, calls Best Idea https://seekingalpha.com/news/3415839-guggenheim-starts-okta-buy-calls-best-idea?source=tweet\" data-url=\"https://seekingalpha.com/news/3415839-guggenheim-starts-okta-buy-calls-best-idea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415836\" data-ts=\"1544478708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBX\" target=\"_blank\">DBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415836-dropbox-box-gain-on-william-blair-initiations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dropbox, Box gain on William Blair initiations</a></h4><ul><li>William Blair starts <a href=\"https://www.streetinsider.com/New+Coverage/William+Blair+Starts+Dropbox+%28DBX%29+at+Outperform/14908329.html\" target=\"_blank\">Dropbox</a> (NASDAQ:<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a>) and <a href=\"https://www.streetinsider.com/New+Coverage/William+Blair+Starts+Box%2C+Inc.+%28BOX%29+at+Outperform/14908341.html\" target=\"_blank\">Box </a>(NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>) with Outperform ratings.</li><li>Late last month, Box reported Q3 beats with in-line guidance.</li><li>Dropbox's Q3 beat estimates and had an upside guide for Q4.</li><li>Dropbox shares are <font color=\"green\">up 1%</font> aftermarket and Box gains <font color=\"green\">0.6%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3412950-box-plus-2_3-percent-q3-beats-line-guide\" target=\"_blank\">Box +2.3% on Q3 beats, in-line guide</a> (Nov. 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3407662-dropbox-plus-5_8-percent-q3-beats\" target=\"_blank\">Dropbox +5.8% on Q3 beats</a> (Nov. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3408138-dropbox-guides-upside-q4\" target=\"_blank\">Dropbox guides upside Q4</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415836\" data-linked=\"Dropbox, Box gain on William Blair initiations\" data-tweet=\"$DBX $DBX $BOX - Dropbox, Box gain on William Blair initiations https://seekingalpha.com/news/3415836-dropbox-box-gain-on-william-blair-initiations?source=tweet\" data-url=\"https://seekingalpha.com/news/3415836-dropbox-box-gain-on-william-blair-initiations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415823\" data-ts=\"1544477519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415823-post-earnings-rally-for-ascena-retail\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings rally for Ascena Retail</a></h4><ul><li>Ascena Retail (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a>) jumps after edging past estimates with its FQ1 report.</li><li>Comparable sales were up 3% during the quarter, led by strength with the Justice brand (+12% comp), Ann Taylor and Loft.</li><li>Gross margin came in at 59.4% of sales vs. 60.7% a year ago and 60.2% consensus.</li><li>Looking ahead, the company expects Q2 sales of $1.68B to $1.71B vs. $1.70B consensus.</li><li>CEO update: \"In parallel with execution of strategic brand growth initiatives, we continue to evaluate all opportunities to increase shareholder value, including ongoing assessment of our brand portfolio, development of our platform capability to enable delivery of third party services, and potential new channels of distribution.\"</li><li>ASNA <font color=\"green\">+5.8%</font> AH to $2.90</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415792-ascena-retail-group-beats-0_02-beats-revenue\" target=\"_blank\">Ascena Retail Group beats by $0.02, beats on revenue</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415823\" data-linked=\"Post-earnings rally for Ascena Retail\" data-tweet=\"$ASNA - Post-earnings rally for Ascena Retail https://seekingalpha.com/news/3415823-post-earnings-rally-for-ascena-retail?source=tweet\" data-url=\"https://seekingalpha.com/news/3415823-post-earnings-rally-for-ascena-retail\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415816\" data-ts=\"1544477059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAC\" target=\"_blank\">SEAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415816-seachange-beats-cuts-guidance-revenues-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaChange beats, but cuts guidance as revenues decline</a></h4><ul>   <li>SeaChange (NASDAQ:<a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a>) topped expectations on top and bottom lines with its Q3 results, though revenues fell nearly 21% and the company cut guidance below consensus.</li>    <li>Cost of revenues on products went up more than 43%, however, pinching gross profit by 31%.</li>    <li>Shares are <font color=\"red\">down 18.5%</font> in relatively light trading after hours.</li>    <li>The company swung to an operating loss of $2.51M, from a year-ago gain of $920,000. Net loss widened to $3.83M from a year-ago loss of $220,000.</li>    <li>Revenue breakout: Products, $8.27M (down 25.6%); Services, $10.34M (down 16%).</li>    <li>Liquidity was $32.4M with no debt outstanding.</li>    <li>It's guiding to Q4 revenue of $16M-$20M (light of expected $25.3M) and EPS of -$0.05 to $0.02 (well short of consensus for $0.14).</li>    <li>For the full year, it's trimmed revenue guidance to $61M-$65M (short of expected $69.7M) and operating income of -$0.34 to -$0.27.</li>    <li><a href=\"https://edge.media-server.com/m6/p/awcdu6xc\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415789-seachange-beats-0_03-beats-revenue\" target=\"_blank\">SeaChange beats by $0.03, beats on revenue</a> (Dec. 10 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17353574-seachange-international-reports-third-quarter-fiscal-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3415816\" data-linked=\"SeaChange beats, but cuts guidance as revenues decline\" data-tweet=\"$SEAC - SeaChange beats, but cuts guidance as revenues decline https://seekingalpha.com/news/3415816-seachange-beats-cuts-guidance-revenues-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3415816-seachange-beats-cuts-guidance-revenues-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415812\" data-ts=\"1544476954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMD\" target=\"_blank\">CRMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415812-cormedix-to-sell-nj-tax-credits-for-5m-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CorMedix to sell NJ tax credits for ~$5M; shares up 2% after hours</a></h4><ul><li>CorMedix (NYSEMKT:<a href='https://seekingalpha.com/symbol/CRMD' title='CorMedix Inc.'>CRMD</a>) <a href=\"https://seekingalpha.com/pr/17353602-cormedix-receives-approval-sell-5_4-million-nol-tax-benefits-new-jersey-economic-development\" target=\"_blank\">announces </a>that the New Jersey Economic Development Authority has signed off on its proposed sale of ~$5.4M in state tax credits to a third party for ~$5M in cash.</li><li>The state's program allows small tech companies to sell up to $15M in accrued tax credits as a way to raise money.</li><li>Shares are up <font color=\"green\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415812\" data-linked=\"CorMedix to sell NJ tax credits for ~$5M; shares up 2% after hours\" data-tweet=\"$CRMD - CorMedix to sell NJ tax credits for ~$5M; shares up 2% after hours https://seekingalpha.com/news/3415812-cormedix-to-sell-nj-tax-credits-for-5m-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3415812-cormedix-to-sell-nj-tax-credits-for-5m-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415801\" data-ts=\"1544476585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415801-weight-watchers-gains-on-m-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weight Watchers gains on M&amp;A hopes</a></h4><ul><li>Weight Watchers (NYSE:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) ended the day <font color=\"green\">up 6.0%</font> after D.A. Davidson suggested that the company could attract a bidder at at a takeover price as high as $67.</li><li>The focus on Weight Watchers increased today after Nutrisystem received a buyout offer of its own.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415552-tivity-health-lands-nutrisystem\" target=\"_blank\">Tivity Health lands Nutrisystem</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415801\" data-linked=\"Weight Watchers gains on M&amp;A hopes\" data-tweet=\"$WTW $WW - Weight Watchers gains on M&amp;A hopes https://seekingalpha.com/news/3415801-weight-watchers-gains-on-m-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3415801-weight-watchers-gains-on-m-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415797\" data-ts=\"1544476341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415797-stitch-fixplus-6-after-strong-fq1-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix +6% after strong FQ1 report</a></h4><ul><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) pops after topping estimates with both lines of its FQ1 report.</li><li>The retailer also posted EBITDA of $14.3M during the quarter vs. $8.0M consensus.</li><li>Stitch Fix's active client list grew 22% to 2.9M during the quarter.</li><li>SFIX <font color=\"green\">+6.08%</font> AH to $27.55.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415795-stitch-fix-beats-0_07-beats-revenue\" target=\"_blank\">Stitch Fix beats by $0.07, beats on revenue</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415797\" data-linked=\"Stitch Fix +6% after strong FQ1 report\" data-tweet=\"$SFIX - Stitch Fix +6% after strong FQ1 report https://seekingalpha.com/news/3415797-stitch-fixplus-6-after-strong-fq1-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3415797-stitch-fixplus-6-after-strong-fq1-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415795\" data-ts=\"1544476257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415795-stitch-fix-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix beats by $0.07, beats on revenue</a></h4><ul><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>): Q1 GAAP EPS of $0.10 <span style=\"color:green\">beats by $0.07</span>.</li><li>Revenue of $366.24M (+23.9% Y/Y) <font color=\"green\">beats by $8.18M</font>.</li><li>Shares <font color=\"green\">+9%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17353599-stitch-fix-announces-first-quarter-fiscal-year-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415795\" data-linked=\"Stitch Fix beats by $0.07, beats on revenue\" data-tweet=\"$SFIX - Stitch Fix beats by $0.07, beats on revenue https://seekingalpha.com/news/3415795-stitch-fix-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3415795-stitch-fix-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415792\" data-ts=\"1544476006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415792-ascena-retail-group-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascena Retail Group beats by $0.02, beats on revenue</a></h4><ul><li>Ascena Retail Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a>): Q1 Non-GAAP EPS of $0.06 <span style=\"color:green\">beats by $0.02</span>; GAAP EPS of $0.03.</li><li>Revenue of $1.59B (flat Y/Y) <font color=\"green\">beats by $30M</font>.</li><li>Shares <font color=\"green\">+15%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17353588-ascena-retail-group-inc-reports-first-quarter-fiscal-2019-results-provides-second-quarter\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415792\" data-linked=\"Ascena Retail Group beats by $0.02, beats on revenue\" data-tweet=\"$ASNA - Ascena Retail Group beats by $0.02, beats on revenue https://seekingalpha.com/news/3415792-ascena-retail-group-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3415792-ascena-retail-group-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415788\" data-ts=\"1544475848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARX\" target=\"_blank\">RARX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415788-ra-pharma-readies-100m-stock-offering-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ra Pharma readies $100M stock offering; shares down 2% after hours</a></h4><ul><li>Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a>) slips <font color=\"red\">2%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17353567-ra-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">$100M stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415788\" data-linked=\"Ra Pharma readies $100M stock offering; shares down 2% after hours\" data-tweet=\"$RARX - Ra Pharma readies $100M stock offering; shares down 2% after hours https://seekingalpha.com/news/3415788-ra-pharma-readies-100m-stock-offering-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3415788-ra-pharma-readies-100m-stock-offering-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415787\" data-ts=\"1544475835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASPU\" target=\"_blank\">ASPU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415787-aspen-beats-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aspen beats by $0.01, misses on revenue</a></h4><ul><li>Aspen (NASDAQ:<a href='https://seekingalpha.com/symbol/ASPU' title='Aspen Group Inc.'>ASPU</a>): Q2 GAAP EPS of -$0.13 <span style=\"color:green\">beats by $0.01</span>.</li><li>Revenue of $8.1M (+67.0% Y/Y) <font color=\"red\">misses by $0.07M</font>.</li><li>Shares <font color=\"green\">+3.89%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17353566-aspen-group-reports-67-percent-revenue-growth-8_1-million-second-quarter-fiscal-2019-12\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415787\" data-linked=\"Aspen beats by $0.01, misses on revenue\" data-tweet=\"$ASPU - Aspen beats by $0.01, misses on revenue https://seekingalpha.com/news/3415787-aspen-beats-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3415787-aspen-beats-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415785\" data-ts=\"1544475539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMES\" target=\"_blank\">EMES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415785-crude-oil-slides-3-giving-up-gains-on-opec-production-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude oil slides 3%, giving up gains on OPEC production deal</a></h4><ul><li><a href=\"https://www.marketwatch.com/story/oil-slips-cant-extend-fridays-opec-led-price-surge-2018-12-10\" target=\"_blank\">Crude oil futures erase the gains</a> they made on Friday following OPEC's decision to cut production: January WTI settled <font color=\"red\">-3.1%</font> to $51/bbl after rising 3.3% last week, and Brent <font color=\"red\">-2.8%</font> ended at $59.97/bbl following last week's 3.7% jump.</li><li>\"It didn\u2019t take long for Friday\u2019s OPEC+ planned production to get priced in as focus turned back to the potential impact of worsening U.S.-China trade tensions,\" says Colin Cieszynski, chief market strategist at SIA Wealth Management.</li><li>Oil\u2019s gains risk being <a href=\"https://www.bloomberg.com/news/articles/2018-12-10/goldman-sachs-and-morgan-stanley-warn-oil-uncertainty-to-persist\" target=\"_blank\">quelled by uncertainty</a> over how the OPEC+ coalition will implement its deal to cut output, Morgan Stanley analysts say.</li><li>While prices can continue to rise as the pact significantly decreases the possibility of a glut, crude\u2019s four-year  high reached in early October is unlikely to be reached again in coming  quarters, Stanley says.</li><li>Goldman Sachs says the oil market may rebalance in H1 2019 as Iranian production is squeezed by U.S. sanctions and a lack of  new pipeline out of the Permian Basin, but the firm is less optimistic about H2 as \"OPEC+ attempts to sequentially grow and  given an expected stabilization in Iran production, the unleashing of  the Permian growth and back-end loaded growth in Canada, Brazil and  Norway.\"</li><li>Among today's notable decliners: <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color=\"red\">-17.9%</font>, <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color=\"red\">-13.9%</font>, <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color=\"red\">-11.5%</font>, <a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a> <font color=\"red\">-10%</font>, <a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color=\"red\">-8.6%</font>, <a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a> <font color=\"red\">-8.2%</font>, MTRD <font color=\"red\">-7.4%</font>, <a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica'>SLCA</a> <font color=\"red\">-7.3%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color=\"red\">-7%</font>, <a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a> <font color=\"red\">-6.5%</font>, <a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a> <font color=\"red\">-6.1%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color=\"red\">-5.3%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"red\">-4.7%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415785\" data-linked=\"Crude oil slides 3%, giving up gains on OPEC production deal\" data-tweet=\"$EMES $EMES $WTI - Crude oil slides 3%, giving up gains on OPEC production deal https://seekingalpha.com/news/3415785-crude-oil-slides-3-giving-up-gains-on-opec-production-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3415785-crude-oil-slides-3-giving-up-gains-on-opec-production-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415773\" data-ts=\"1544473998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAO\" target=\"_blank\">AKAO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415773-achaogen-up-24-after-fda-nod-on-plazomicin-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achaogen up 24% after FDA nod on plazomicin test</a></h4><ul><li>Nano cap Achaogen (<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color=\"green\">+23.7%</font>) is up on double normal volume. This morning, it <a href=\"https://seekingalpha.com/pr/17352802-achaogen-announces-fda-clearance-launch-thermo-scientific-qms-plazomicin-immunoassay\" target=\"_blank\">announced </a>that the FDA has cleared Thermo Fisher Scientific's QMS Plazomicin Immunoassay that quantitatively measures the amount of plazomicin in human plasma. The test, performed on TMO's automated analyzers, will be used as an aid in the management of patients with complicated urinary tract infections (cUTIs) who are receiving the drug, branded as ZEMDRI.</li><li>The stock has been in a consistent down trend since June when the FDA approved the drug for cUTI but not for bloodstream infections. Shares have sold off ~<font color=\"red\">86%</font> since then.</li><li>On the working capital front, at the end of September it had $58.2M in quick assets while operations consumed $133.3M during the first three quarters of the year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3352023-achaogen-26-percent-premarket-ad-com-vote\" target=\"_blank\">Achaogen down 26% premarket after Ad Com vote</a> (May 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415773\" data-linked=\"Achaogen up 24% after FDA nod on plazomicin test\" data-tweet=\"$AKAO - Achaogen up 24% after FDA nod on plazomicin test https://seekingalpha.com/news/3415773-achaogen-up-24-after-fda-nod-on-plazomicin-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3415773-achaogen-up-24-after-fda-nod-on-plazomicin-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415764\" data-ts=\"1544472063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPER\" target=\"_blank\">XPER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415764-xperi-veritone-and-xperi-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xperi, Veritone and Xperi among  tech movers</a></h4><ul><li><strong>Gainers: </strong>Xperi (NASDAQ:<a href='https://seekingalpha.com/symbol/XPER' title='Xperi Corporation'>XPER</a>) <font color=\"green\">+46%</font>. Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>) <font color=\"green\">+22%</font>. Systemax (NYSE:<a href='https://seekingalpha.com/symbol/SYX' title='Systemax Inc.'>SYX</a>) <font color=\"green\">+18%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"green\">+16%</font>. SolarWinds (NYSE:<a href='https://seekingalpha.com/symbol/SWI' title='SolarWinds, Inc.'>SWI</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers: </strong>China Finance Online (NASDAQ:<a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a>) <font color=\"red\">-20%</font>. Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) <font color=\"red\">-18%</font>. Marin Software (NASDAQ:<a href='https://seekingalpha.com/symbol/MRIN' title='Marin Software'>MRIN</a>) <font color=\"red\">-12%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd Sponsored ADR'>SFET</a>) <font color=\"red\">-12%</font>. Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415764\" data-linked=\"Xperi, Veritone and Xperi among  tech movers\" data-tweet=\"$XPER $XPER $VERI - Xperi, Veritone and Xperi among tech movers https://seekingalpha.com/news/3415764-xperi-veritone-and-xperi-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415764-xperi-veritone-and-xperi-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415760\" data-ts=\"1544470878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESTC\" target=\"_blank\">ESTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415760-elastic-doubles-down-on-open-source-commitment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elastic doubles down on open source commitment</a></h4><ul><li>Elastic (NYSE:<a href='https://seekingalpha.com/symbol/ESTC' title='Elastic'>ESTC</a>) <a href=\"https://seekingalpha.com/pr/17353259-elastic-joins-cloud-native-computing-foundation-cncf-launches-helm-charts-elasticsearch\" target=\"_blank\">announces</a> joining the Cloud Native Computing Foundation to increase its commitment to open cloud native technologies.</li><li>In tandem, Elastic announces that it's now possible to deploy Elasticsearch and Kibana to Kubernetes with Helm, the Kubernetes package manager. </li><li>Elastic shares are <font color=\"green\">up 6.5%</font> to $73.60.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415760\" data-linked=\"Elastic doubles down on open source commitment\" data-tweet=\"$ESTC - Elastic doubles down on open source commitment https://seekingalpha.com/news/3415760-elastic-doubles-down-on-open-source-commitment?source=tweet\" data-url=\"https://seekingalpha.com/news/3415760-elastic-doubles-down-on-open-source-commitment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415759\" data-ts=\"1544470691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415759-suntrust-comparables-suggest-yelp-draw-50-share-in-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust: Comparables suggest Yelp could draw $50/share in sale</a></h4><ul>   <li>Weighing a potential sale of Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>), SunTrust suggests the company could be worth closer to $50/share in a transaction after looking at recent transactions.</li>    <li>Yelp's <font color=\"green\">up 2.9%</font> currently to $35.59/share; holder SQN Investors wrote a <a href=\"https://seekingalpha.com/news/3415575-longtime-investor-pushes-yelp-changes\" target=\"_blank\">letter to the board</a> asking for new members and consideration of a sale, saying its patience has worn out.</li>    <li>SunTrust is looking to recent sales of Pandora and Web.com coming at about four times 2019 enterprise value/gross profit, suggesting the companies are alike because of big insider sales forces and similar operating expenditure structures. (h/t Bloomberg)</li>    <li>It's sticking with a Hold rating and $35 price target as is.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415759\" data-linked=\"SunTrust: Comparables suggest Yelp could draw $50/share in sale\" data-tweet=\"$YELP - SunTrust: Comparables suggest Yelp could draw $50/share in sale https://seekingalpha.com/news/3415759-suntrust-comparables-suggest-yelp-draw-50-share-in-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3415759-suntrust-comparables-suggest-yelp-draw-50-share-in-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415755\" data-ts=\"1544469601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415755-fortinetplus-4-on-securing-global-network-for-indian-distributor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortinet +4% on securing global network for Indian distributor</a></h4><ul><li>Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) <a href=\"https://seekingalpha.com/pr/17352989-fortinet-secures-global-network-dtdc-express-india-s-second-largest-express-distribution\" target=\"_blank\">announces</a> that Indian distribution and logistics company DTDC Express bolstered its existing Fortinet Security Fabric deployment by modernizing data center and branch firewalls.</li><li>The existing deployment spans 30 global offices and 450 branches.</li><li>FTNT is <font color=\"green\">up 3.9%</font> to $74.43.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415755\" data-linked=\"Fortinet +4% on securing global network for Indian distributor\" data-tweet=\"$FTNT - Fortinet +4% on securing global network for Indian distributor https://seekingalpha.com/news/3415755-fortinetplus-4-on-securing-global-network-for-indian-distributor?source=tweet\" data-url=\"https://seekingalpha.com/news/3415755-fortinetplus-4-on-securing-global-network-for-indian-distributor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415748\" data-ts=\"1544468841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWST\" target=\"_blank\">TWST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415748-twist-bio-down-14-on-expanded-agilent-complaint-over-alleged-theft-of-trade-secrets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twist Bio down 14% on expanded Agilent complaint over alleged theft of trade secrets</a></h4><ul><li>Twist Bioscience (<a href='https://seekingalpha.com/symbol/TWST' title='Twist Bioscience Corporation'>TWST</a> <font color=\"red\">-13.8%</font>) slumps on modestly higher volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1581280/000119312518345554/d667816d8k.htm\" target=\"_blank\">disclosure </a>that a California court has granted plaintiff Agilent's (<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies Inc.'>A</a> <font color=\"red\">-0.2%</font>) motion to <a href=\"https://www.agilent.com/about/newsroom/presrel/2018/18sep-gp18053.html\" target=\"_blank\">add two additional defendants</a>, current TWST employee Dr. Siyuan Chen, and former CFO Solange Glaize, to its lawsuit claiming that the company and certain employees stole confidential documents related to its proprietary oligonucleotide synthesis technology.</li><li>The court denied its motion for a protective order and set no limits on discovery.</li><li>Agilent filed suit against the company and CEO Emily Leproust in February 2016. The trial date is February 24, 2020. Unsurprisingly, the defendants intend to \"vigorously\" dispute the allegations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415748\" data-linked=\"Twist Bio down 14% on expanded Agilent complaint over alleged theft of trade secrets\" data-tweet=\"$TWST $TWST $A - Twist Bio down 14% on expanded Agilent complaint over alleged theft of trade secrets https://seekingalpha.com/news/3415748-twist-bio-down-14-on-expanded-agilent-complaint-over-alleged-theft-of-trade-secrets?source=tweet\" data-url=\"https://seekingalpha.com/news/3415748-twist-bio-down-14-on-expanded-agilent-complaint-over-alleged-theft-of-trade-secrets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415746\" data-ts=\"1544468393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGP\" target=\"_blank\">FGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415746-ferrellgas-partners-and-silvercrest-metals-among-energy-materials-gainers-sundance-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferrellgas Partners and SilverCrest Metals among Energy/Materials gainers; Sundance Energy Australia and Mountain Province Diamonds among losers</a></h4><ul><li><b>Gainers: </b>Ferrellgas Partners (NYSE:<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a>) <font color=\"green\">+8%</font>. SilverCrest Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals, Inc.'>SILV</a>) <font color=\"green\">+8%</font>. Ultra Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a>) <font color=\"green\">+6%</font>. Superior Drilling Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Sundance Energy Australia (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia'>SNDE</a>) <font color=\"red\">-15%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-15%</font>. Marrone Bio Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a>) <font color=\"red\">-12%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-12%</font>. Earthstone Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTE' title='Earthstone Energy, Inc.'>ESTE</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415746\" data-linked=\"Ferrellgas Partners and SilverCrest Metals among Energy/Materials gainers; Sundance Energy Australia and Mountain Province Diamonds among losers\" data-tweet=\"$FGP $FGP $SILV - Ferrellgas Partners and SilverCrest Metals among Energy/Materials gainers; Sundance Energy Australia and Mountain Province Diamonds among losers https://seekingalpha.com/news/3415746-ferrellgas-partners-and-silvercrest-metals-among-energy-materials-gainers-sundance-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3415746-ferrellgas-partners-and-silvercrest-metals-among-energy-materials-gainers-sundance-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415747\" data-ts=\"1544468386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415747-mizuho-cuts-western-digitals-target-on-nand-ssd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho cuts Western Digital&#39;s target on NAND, SSD</a></h4><ul><li>Mizuho maintains a Neutral rating on Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) and drops the target from $55 to $49.</li><li>Analyst Vijay Rakesh joins the voices warning on NAND pricing.</li><li>Rakesh: \"We continue to see challenges for WDC as NAND pricing continues to decline with seasonality, and challenges from handsets, tariffs and macro demand affect visibility.:</li><li>The analyst says WDC faces slower datacenter spend with inventory headwinds and thinks supply and seasonality could drive further revenue and margin declines into 1H19 as SSD pricing declines.</li><li>Source: Bloomberg First Word.</li><li>Western Digital shares are <font color=\"red\">down 1.3%</font> to $41.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415682-micron-minus-1_8-percent-citi-estimate-cut\" target=\"_blank\">Micron -1.8% on Citi estimate cut</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415747\" data-linked=\"Mizuho cuts Western Digital&#39;s target on NAND, SSD\" data-tweet=\"$WDC - Mizuho cuts Western Digital&#39;s target on NAND, SSD https://seekingalpha.com/news/3415747-mizuho-cuts-western-digitals-target-on-nand-ssd?source=tweet\" data-url=\"https://seekingalpha.com/news/3415747-mizuho-cuts-western-digitals-target-on-nand-ssd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415735\" data-ts=\"1544465384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415735-piper-jaffray-positive-on-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray positive on Chipotle</a></h4><ul> <li>Piper Jaffray thinks an <a href=\"https://www.barrons.com/articles/chipotle-stock-could-get-a-lift-from-marketing-1544464644?mod=hp_LATEST\" target=\"_blank\">improvement</a> in Chipotle's (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+0.3%</font>) brand awareness through a higher marketing spend will lead to same-store sales growth.</li> <li>\"The company is increasing Chipotle brand awareness through marketing efforts that today promote brand equity, but with a long-term plan that incorporates calls to action and iconic visual elements,\" advises analyst Nicole Miller Regan.</li> <li>Piper thinks Chipotle (Overweight, $550 price target) will generate same-store sales growth of 4% in Q4.</li> <li>Shares of Chipotle are up 62% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415735\" data-linked=\"Piper Jaffray positive on Chipotle\" data-tweet=\"$CMG - Piper Jaffray positive on Chipotle https://seekingalpha.com/news/3415735-piper-jaffray-positive-on-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3415735-piper-jaffray-positive-on-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415734\" data-ts=\"1544465361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415734-u-s-stock-markets-mixed-nasdaq-edges-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. stock markets mixed as Nasdaq edges up</a></h4><ul><li>The tech-heavy Nasdaq creeps up to a gain in early afternoon trading as the Dow and S&amp;P 500 pare earlier losses.</li><li>Nasdaq <font color=\"green\">+0.2%</font>, S&amp;P <font color=\"red\">-0.5%</font>, Dow <font color=\"red\">-0.7%</font>.</li><li>By sector, technology rises 0.3%. Among individual stocks, Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.1%</font>), Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='green'>+2.1%</font>), and Microsoft (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a> <font color='green'>+1.2%</font>) advance.</li><li>Financials <font color=\"red\">-1.4%</font> and basic materials <font color=\"red\">-1.4%</font>, which includes oil &amp; gas, experience the biggest sector declines. Individual laggards include Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-3%</font>), Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color='red'>-2.9%</font>), Citi (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='red'>-2.4%</font>), Occidental Petroleum (<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-3.5%</font>), Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-2.4%</font>), and EOG Resources (<a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color='red'>-2.7%</font>).</li><li>Crude <font color=\"red\">slides 1.5%</font> to $51.81.</li><li>U.S. 10-year Treasury price slips, lifting yield by almost 1 basis point to 2.86%. Dollar index <font color=\"green\">rises 0.5%</font> to 97.14.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415640-stock-losses-mount-amid-growth-concerns-trade-uncertainty\" target=\"_blank\">Stock losses mount amid growth concerns, trade uncertainty</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415734\" data-linked=\"U.S. stock markets mixed as Nasdaq edges up\" data-tweet=\"$GOOG $GOOG $FB - U.S. stock markets mixed as Nasdaq edges up https://seekingalpha.com/news/3415734-u-s-stock-markets-mixed-nasdaq-edges-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3415734-u-s-stock-markets-mixed-nasdaq-edges-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415731\" data-ts=\"1544465333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIXX\" target=\"_blank\">FIXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415731-homology-medicines-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homology Medicines up 4%</a></h4><ul><li>Thinly traded gene therapy developer Homology Medicines (<a href='https://seekingalpha.com/symbol/FIXX' title='Homology Medicines'>FIXX</a> <font color=\"green\">+3.6%</font>) is up on below-average volume. Shares have rallied over <font color=\"green\">42%</font> since touching $18.20 on November 21.</li><li>The stock debuted at $16 in late March. Lead candidate is Phase 1/2-stage HMI-102 for phenylketonuria.</li><li>Other gene therapy players in the green: (<a href='https://seekingalpha.com/symbol/MGTX' title='MeiraGTx Holdings plc'>MGTX</a> <font color=\"green\">+1.9%</font>)(<a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc'>GNPX</a> <font color=\"green\">+3.3%</font>)(<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"green\">+4.1%</font>)(<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color=\"green\">+1.6%</font>)(<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color=\"green\">+0.4%</font>)(<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color=\"green\">+2.3%</font>)(<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color=\"green\">+2%</font>)(<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a> <font color=\"green\">+0.3%</font>)(<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color=\"green\">+1.3%</font>)(<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color=\"green\">+0.2%</font>)(<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color=\"green\">+1.1%</font>)(<a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color=\"green\">+0.8%</font>)(<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"green\">+1.9%</font>)(<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color=\"green\">+4.2%</font>)(<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color=\"green\">+0.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415731\" data-linked=\"Homology Medicines up 4%\" data-tweet=\"$FIXX $FIXX $MGTX - Homology Medicines up 4% https://seekingalpha.com/news/3415731-homology-medicines-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3415731-homology-medicines-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415730\" data-ts=\"1544465046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415730-apple-reversal-leads-market-bounce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple reversal leads market bounce</a></h4><ul><li>Markets are well off session lows in afternoon action, in part thanks to a speedy reversal in the shares of Apple.</li><li>Apple earlier was <font color=\"red\">down more than 2%</font> as Qualcomm reported winning a ban on the sale of some iPhones in China. That decline has been completely eliminated over the past 30 minutes.</li><li><font color=\"red\">Down nearly 2%</font> earlier, the S&amp;P 500 has narrowed that to <font color=\"red\">just 0.6%</font>. The Dow is <font color=\"red\">off 0.8%</font>, and the Nasdaq has turned <font color=\"green\">barely positive</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415730\" data-linked=\"Apple reversal leads market bounce\" data-tweet=\"Apple reversal leads market bounce https://seekingalpha.com/news/3415730-apple-reversal-leads-market-bounce?source=tweet\" data-url=\"https://seekingalpha.com/news/3415730-apple-reversal-leads-market-bounce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415729\" data-ts=\"1544465027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HX\" target=\"_blank\">HX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415729-hexindai-leads-financial-gainers-lm-funding-america-and-lexinfintech-holdings-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hexindai leads financial gainers; LM Funding America and LexinFintech Holdings among losers</a></h4><ul><li><b>Gainers: </b>Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"green\">+39%</font>. Siebert Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a>) <font color=\"green\">+10%</font>. eXp World Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPI' title='eXp World Holdings, Inc.'>EXPI</a>) <font color=\"green\">+7%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+7%</font>. Yintech Investment Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/YIN' title='Yintech Investment Holdings'>YIN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>) <font color=\"red\">-19%</font>. Och-Ziff Capital Management Group (NYSE:<a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a>) <font color=\"red\">-10%</font>. LexinFintech Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a>) <font color=\"red\">-9%</font>. LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"red\">-7%</font>. Bancorp Of New Jersey (NYSEMKT:<a href='https://seekingalpha.com/symbol/BKJ' title='Bancorp of New Jersey, Inc.'>BKJ</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415729\" data-linked=\"Hexindai leads financial gainers; LM Funding America and LexinFintech Holdings among losers\" data-tweet=\"$HX $HX $SIEB - Hexindai leads financial gainers; LM Funding America and LexinFintech Holdings among losers https://seekingalpha.com/news/3415729-hexindai-leads-financial-gainers-lm-funding-america-and-lexinfintech-holdings-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415729-hexindai-leads-financial-gainers-lm-funding-america-and-lexinfintech-holdings-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415726\" data-ts=\"1544464426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACET\" target=\"_blank\">ACET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415726-generics-under-pressure-on-expanded-price-fixing-investigation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Generics under pressure on expanded price-fixing investigation</a></h4><ul><li>The broad market's bearishness notwithstanding, generic drug makers are predominantly in the red on the news that the investigation into alleged price-fixing by state AGs now totals 47.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a>)(<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics'>ACRS</a> <font color=\"red\">-3.3%</font>)(<a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color=\"green\">+0.8%</font>)(<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a> <font color=\"red\">-1.9%</font>)(<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a> <font color=\"red\">-5.2%</font>)(<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a>)(<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"red\">-3.9%</font>)(<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a> <font color=\"red\">-3.5%</font>)(<a href='https://seekingalpha.com/symbol/COLL' title='Collegium Pharmaceutical'>COLL</a> <font color=\"red\">-1.9%</font>)(<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color=\"green\">+0.2%</font>)(<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-3.1%</font>)(<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color=\"red\">-2.6%</font>)(<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a> <font color=\"red\">-2.6%</font>)(<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color=\"red\">-3.2%</font>)(<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color=\"red\">-2.6%</font>)(<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"red\">-2.9%</font>)(<a href='https://seekingalpha.com/symbol/TLGT' title='Teligent, Inc.'>TLGT</a> <font color=\"green\">+3.7%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-7.2%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415542-teva-3-percent-premarket-expanded-investigation-generic-drug-price-fixing\" target=\"_blank\">Teva down 3% premarket on expanded investigation into generic drug price fixing</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415726\" data-linked=\"Generics under pressure on expanded price-fixing investigation\" data-tweet=\"$ACET $ACET $ACRS - Generics under pressure on expanded price-fixing investigation https://seekingalpha.com/news/3415726-generics-under-pressure-on-expanded-price-fixing-investigation?source=tweet\" data-url=\"https://seekingalpha.com/news/3415726-generics-under-pressure-on-expanded-price-fixing-investigation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415723\" data-ts=\"1544463721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPER\" target=\"_blank\">XPER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415723-himx-axon-and-mrns-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HIMX, AXON and MRNS among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>Xperi (NASDAQ:<a href='https://seekingalpha.com/symbol/XPER' title='Xperi Corporation'>XPER</a>) <font color=\"green\">+43%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"green\">+38%</font>. Innovate Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a>) <font color=\"green\">+37%</font>. Nutrisystem (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a>) <font color=\"green\">+29%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"green\">+17%</font>. Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>) <font color=\"green\">+17%</font>. Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals'>RARX</a>) <font color=\"green\">+14%</font>. Kiniksa Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KNSA' title='Kiniksa Pharmaceuticals'>KNSA</a>) <font color=\"green\">+14%</font>. Systemax (NYSE:<a href='https://seekingalpha.com/symbol/SYX' title='Systemax Inc.'>SYX</a>) <font color=\"green\">+14%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"green\">+12%</font>. Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>Tivity Health (NASDAQ:<a href='https://seekingalpha.com/symbol/TVTY' title='Tivity Health, Inc.'>TVTY</a>) <font color=\"red\">-31%</font>. MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) <font color=\"red\">-26%</font>. Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) <font color=\"red\">-25%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-22%</font>. Marine Products (NYSE:<a href='https://seekingalpha.com/symbol/MPX' title='Marine Products Corporation'>MPX</a>) <font color=\"red\">-21%</font>. Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a>) <font color=\"red\">-19%</font>. China Finance Online (NASDAQ:<a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a>) <font color=\"red\">-16%</font>. Himax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a>) <font color=\"red\">-16%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a>) <font color=\"red\">-15%</font>. Gritstone Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/GRTS' title='Gritstone Oncology'>GRTS</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415723\" data-linked=\"HIMX, AXON and MRNS among notable midday movers\" data-tweet=\"$XPER $XPER $HX - HIMX, AXON and MRNS among notable midday movers https://seekingalpha.com/news/3415723-himx-axon-and-mrns-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3415723-himx-axon-and-mrns-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415716\" data-ts=\"1544462429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415716-tech-lunch-apples-china-woes-weigh-semis-strong\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech lunch: Apple&#39;s China woes weigh, semis strong</a></h4><ul><li>The tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) <font color=\"red\">drops 0.3%</font> as the Huawei CFO arrest continues to stoke fears of US-China trade tensions and Qualcomm <font color=\"green\">+3.4%</font> announces a preliminary Apple <font color=\"red\">-2%</font> iPhone ban in China due to patent infringement. Add in the production cut for iPhone XR supplier Japan Display and a downgrade for Qorvo <font color=\"red\">-3%</font> and this is another rocky day for the Apple supply chain.</li><li>The S&amp;P 500 IT Index is <font color=\"red\">down 1.4%,</font> the Nasdaq 100 drops <font color=\"red\">0.5%</font>, and the Philadelphia Semiconductor Index stands apart in <font color=\"green\">gaining 0.5%</font>. Compare to the <font color=\"red\">1.6%</font>, <font color=\"red\">1.3%</font>, and<font color=\"red\"> 0.7% </font>for the Dow, S&amp;P 500, and Nasdaq, respectively.</li><li>Related Chinese tech ETFs: <a href='https://seekingalpha.com/symbol/KWEB' title='KraneShares CSI China Internet ETF'>KWEB</a>, <a href='https://seekingalpha.com/symbol/CQQQ' title='Invesco China Technology ETF'>CQQQ</a>, <a href='https://seekingalpha.com/symbol/QQQC-OLD' title='Global X China Technology ETF'>QQQC-OLD</a>, <a href='https://seekingalpha.com/symbol/CWEB' title='Direxion Daily CSI China Internet Index Bull 2x Shares ETF'>CWEB</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3415602-qualcomm-wins-preliminary-iphone-ban-china-update\" target=\"_blank\">Qualcomm wins preliminary iPhone ban in China (update)</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415716\" data-linked=\"Tech lunch: Apple&#39;s China woes weigh, semis strong\" data-tweet=\"$XLK $KWEB $CQQQ - Tech lunch: Apple&#39;s China woes weigh, semis strong https://seekingalpha.com/news/3415716-tech-lunch-apples-china-woes-weigh-semis-strong?source=tweet\" data-url=\"https://seekingalpha.com/news/3415716-tech-lunch-apples-china-woes-weigh-semis-strong\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415712\" data-ts=\"1544462346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNT\" target=\"_blank\">INNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415712-innovate-bio-up-23\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Innovate Bio up 23%</a></h4><ul><li>Nano cap Innovate Biopharmaceuticals (<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color=\"green\">+22.8%</font>) bucks the broad market selloff on 65% higher volume. Shares are still down ~<font color=\"red\">90%</font>, however, since July.</li><li>Last week, it <a href=\"https://seekingalpha.com/pr/17349007-innovate-biopharmaceuticals-enters-collaboration-massachusetts-general-hospital-announces\" target=\"_blank\">announced </a>a collaboration with Massachusetts General Hospital aimed at understanding how certain toxins in the intestines may cause liver disease via breaching the gut vascular barrier via ethanol-induced disruption. The company expects the research to enhance its knowledge of how agents like larazotide may prevent the \"leaky\" barrier from worsening, thereby providing a potential treatment benefit in patients with liver disorders like NASH.</li><li>On the working capital front, at the end of September it had $8.1M in cash and equivalents while operations consumed $12.8M during the first three quarters of the year.</li><li>In late October, it inked <a href=\"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000045/prospectussuppl.htm\" target=\"_blank\">agreements </a>with H.C. Wainwright and Ladenburg Thalmann for the at-the-market sale of up to $40M of common stock.</li><li>Next Monday, December 17, management will host an investor update during which it will review its capital plan for its celiac disease clinical program and its NASH development strategy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415712\" data-linked=\"Innovate Bio up 23%\" data-tweet=\"$INNT - Innovate Bio up 23% https://seekingalpha.com/news/3415712-innovate-bio-up-23?source=tweet\" data-url=\"https://seekingalpha.com/news/3415712-innovate-bio-up-23\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415713\" data-ts=\"1544461862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415713-mattel-hasbro-drop-on-amazons-private-label-toys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mattel, Hasbro drop on Amazon&#39;s private label toys</a></h4><ul><li>Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color=\"red\">-1.2%</font>) is launching its first private label line of toys for toddlers and kids. <a href=\"https://this.just.in/amazon-launching-first-private-label-toys-for-toddlers-and-kids/\" target=\"_blank\">TJI Research</a> spotted the AmazonBasics product pages for some products, though shipping isn't yet available.</li><li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) shares are <font color=\"red\">down 4.5%</font> while Hasbro (NASDAQ:<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>) <font color=\"red\">drops 2.4%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415713\" data-linked=\"Mattel, Hasbro drop on Amazon&#39;s private label toys\" data-tweet=\"$AMZN $AMZN $MAT - Mattel, Hasbro drop on Amazon&#39;s private label toys https://seekingalpha.com/news/3415713-mattel-hasbro-drop-on-amazons-private-label-toys?source=tweet\" data-url=\"https://seekingalpha.com/news/3415713-mattel-hasbro-drop-on-amazons-private-label-toys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415709\" data-ts=\"1544461363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXDC\" target=\"_blank\">CXDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415709-china-xd-plastics-single-consumer-gainer-navistar-international-and-orchids-paper-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China XD Plastics single consumer gainer; Navistar International and Orchids Paper Products among losers</a></h4><ul><li><b>Gainers: </b>China XD Plastics Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CXDC' title='China XD Plastics Company Limited'>CXDC</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Marine Products (NYSE:<a href='https://seekingalpha.com/symbol/MPX' title='Marine Products Corporation'>MPX</a>) <font color=\"red\">-17%</font>. REV Group (NYSE:<a href='https://seekingalpha.com/symbol/REVG' title='REV Group'>REVG</a>) <font color=\"red\">-13%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp'>PLAG</a>) <font color=\"red\">-9%</font>. Navistar International (NYSE:<a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a>) <font color=\"red\">-8%</font>. Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415709\" data-linked=\"China XD Plastics single consumer gainer; Navistar International and Orchids Paper Products among losers\" data-tweet=\"$CXDC $CXDC $MPX - China XD Plastics single consumer gainer; Navistar International and Orchids Paper Products among losers https://seekingalpha.com/news/3415709-china-xd-plastics-single-consumer-gainer-navistar-international-and-orchids-paper-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3415709-china-xd-plastics-single-consumer-gainer-navistar-international-and-orchids-paper-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415702\" data-ts=\"1544460334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMLEF\" target=\"_blank\">CMLEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415702-cominar-real-estate-jumps-after-tsx-approves-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cominar Real Estate jumps after TSX approves buyback</a></h4><ul><li>Cominar Real Estate Investment (<a href='https://seekingalpha.com/symbol/CMLEF' title='Cominar Real Estate Investment Trust'>OTCPK:CMLEF</a>) rises after receiving<a href=\"https://seekingalpha.com/pr/17352804-normal-course-issuer-bid\" target=\"_blank\"> approval of the Toronto Stock Exchange </a>to buy back up to 18.1M of its units, representing about 10% of its public float.</li><li>Cominar also announces that it has implemented an automatic purchase plan with a broker in order to facilitate repurchases of its units under its normal course issuer bid.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3408179-cominar-real-estate-investment-trust-reports-q3-results\" target=\"_blank\">Cominar Real Estate Investment Trust reports Q3 results</a> (Nov. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415702\" data-linked=\"Cominar Real Estate jumps after TSX approves buyback\" data-tweet=\"$CMLEF - Cominar Real Estate jumps after TSX approves buyback https://seekingalpha.com/news/3415702-cominar-real-estate-jumps-after-tsx-approves-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3415702-cominar-real-estate-jumps-after-tsx-approves-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415701\" data-ts=\"1544460263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415701-susquehanna-confident-on-canada-goose\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna confident on Canada Goose</a></h4><ul> <li>Susquehanna initiates coverage on Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='red'>-3.6%</font>)with a Positive rating.</li> <li>The investment firm calls Canada Goose a best-in-class, luxury, aspirational cold-weather brand with \"significant growth potential\" ahead.</li> <li>Susquehanna sets a price target of C$98, above the consensus PT of C$92 and 52-week high of C$95.62.</li><li>Sources: Marketwatch, Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415701\" data-linked=\"Susquehanna confident on Canada Goose\" data-tweet=\"$GOOS - Susquehanna confident on Canada Goose https://seekingalpha.com/news/3415701-susquehanna-confident-on-canada-goose?source=tweet\" data-url=\"https://seekingalpha.com/news/3415701-susquehanna-confident-on-canada-goose\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415699\" data-ts=\"1544460182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDI\" target=\"_blank\">SDI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415699-standard-diversified-to-acquire-tri-state-consumer-insurance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Standard Diversified to acquire Tri-State Consumer Insurance</a></h4><ul> <li>Standard Diversified (NYSEMKT:<a href='https://seekingalpha.com/symbol/SDI' title='Standard Diversified Inc. Class A'>SDI</a>) to acquire       the holding company of Tri-State Consumer Insurance Co. from WT Holdings and its affiliates, for ~$54.1M, consisting of $25M Series A convertible redeemable preferred stock at a price equal to 120% of 30-day volume weighted average price on the closing date, and the balance to be paid in cash at closing.</li>     <li>This transaction provides significant economies of scale and operating       synergies via the integration of Tri-State with SDI\u2019s existing insurance       subsidiary, Maidstone Insurance.</li><li>Closing of the       transaction shall be subject to final approval by the New York State       Department of Financial Services.</li>     <li>SDI has a right to       terminate the agreement in its sole discretion prior to the end of this       seventy-five day period.</li>     <li>SDI is <font color=\"red\">-11.35%</font>  to $12.50</li><li>Source: <a href=\"https://seekingalpha.com/pr/17352894-standard-diversified-inc-enters-stock-purchase-agreement-acquire-tri-state-consumer-insurance\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415699\" data-linked=\"Standard Diversified to acquire Tri-State Consumer Insurance\" data-tweet=\"$SDI - Standard Diversified to acquire Tri-State Consumer Insurance https://seekingalpha.com/news/3415699-standard-diversified-to-acquire-tri-state-consumer-insurance?source=tweet\" data-url=\"https://seekingalpha.com/news/3415699-standard-diversified-to-acquire-tri-state-consumer-insurance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415696\" data-ts=\"1544459778\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AJRD\" target=\"_blank\">AJRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415696-defense-companies-jump-trump-backs-750b-defense-budget-request\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Defense companies jump as Trump backs $750B defense budget request</a></h4><ul><li>Defense companies are among the few winners in today's stock market slide, following reports that Pres. Trump has told Defense Secretary Mattis to <a href=\"https://www.politico.com/story/2018/12/09/trump-pentagon-defense-spending-budget-1054068\" target=\"_blank\">submit a  $750B budget proposal</a> for FY 2020, in a reversal from his earlier pledge to trim defense spending.</li><li>The $750B figure emerged from a meeting last Tuesday at the White  House among Trump, Mattis and the Republican chairmen of the House and  Senate Armed Services committees, Politico reported over the weekend.</li><li>Trump had said in October that the defense figure for 2020 would be $700B, a ~5% cut in line with decreases planned for  other agencies.</li><li>Top weapons makers are higher: <a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc'>AJRD</a> <font color=\"green\">+2.8%</font>, <a href='https://seekingalpha.com/symbol/LMT' title='Lockheed Martin'>LMT</a> <font color=\"green\">+2.2%</font>, <a href='https://seekingalpha.com/symbol/NOC' title='Northrop Grumman Corporation'>NOC</a> <font color=\"green\">+1.7%</font>, <a href='https://seekingalpha.com/symbol/RTN' title='Raytheon Company'>RTN</a> <font color=\"green\">+1.7%</font>, <a href='https://seekingalpha.com/symbol/GD' title='General Dynamics Corporation'>GD</a> <font color=\"green\">+1.5%</font>, <a href='https://seekingalpha.com/symbol/LLL' title='L3 Technologies'>LLL</a> <font color=\"green\">+0.8%</font>, <a href='https://seekingalpha.com/symbol/BAESY' title='BAE Systems PLC ADR'>OTCPK:BAESY</a> <font color=\"green\">+0.6%</font>, <a href='https://seekingalpha.com/symbol/HRS' title='Harris Corporation'>HRS</a> <font color=\"green\">+0.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415696\" data-linked=\"Defense companies jump as Trump backs $750B defense budget request\" data-tweet=\"$AJRD $AJRD $LMT - Defense companies jump as Trump backs $750B defense budget request https://seekingalpha.com/news/3415696-defense-companies-jump-trump-backs-750b-defense-budget-request?source=tweet\" data-url=\"https://seekingalpha.com/news/3415696-defense-companies-jump-trump-backs-750b-defense-budget-request\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415695\" data-ts=\"1544459336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TME\" target=\"_blank\">TME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415695-tencent-music-to-contest-arbitration-claim-ahead-of-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tencent Music to contest arbitration claim ahead of IPO</a></h4><ul>   <li>Tencent Music (NYSE:<a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a>) and its co-president, Guomin Xie, says they were made aware last week of an investor filing arbitration in China ahead of a U.S. IPO, and that they plan to contest the claims.</li>    <li>In a <a href=\"https://www.sec.gov/Archives/edgar/data/1744676/000119312518345481/d624633dfwp.htm\" target=\"_blank\">free writing prospectus issued today</a>, the company notes that on Dec. 6 it became aware of the arbitration filed by early investor Hanwei Guo, which named Xie, his firm CMC and certain affiliates as respondents.</li>    <li>Guo says he was defrauded and threatened into signing a series of agreements to relinquish interests in a number of entities tied to Ocean Music at below-market value. Those entities came together as part of an acquisition by Tencent (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color=\"red\">-2.8%</font>) to become Tencent Music Entertainment, now pursuing a blockbuster U.S. debut.</li>    <li>Guo is seeking to invalidate the transfer of Ocean Music to Xie, along with damages of about 100M yuan (about $14.6M).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415695\" data-linked=\"Tencent Music to contest arbitration claim ahead of IPO\" data-tweet=\"$TME $TME $TCEHY - Tencent Music to contest arbitration claim ahead of IPO https://seekingalpha.com/news/3415695-tencent-music-to-contest-arbitration-claim-ahead-of-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3415695-tencent-music-to-contest-arbitration-claim-ahead-of-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415693\" data-ts=\"1544459321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAV\" target=\"_blank\">NAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415693-goldman-gloom-hits-navistar-and-oshkosh\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman gloom hits Navistar and Oshkosh</a></h4><ul> <li>Navistar (<a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a> <font color='red'>-9.5%</font>) and Oshkosh (<a href='https://seekingalpha.com/symbol/OSK' title='Oshkosh Corporation'>OSK</a> <font color='red'>-5.3%</font>) fall sharply after both companies take on a downgrade today from Goldman Sachs to a Sell rating from Neutral.</li> <li>The truck makers are getting caught up in a negative stance from Goldman on the broader engineering and construction sectors due to oversupply concerns.</li> <li>The GS analyst team lowers its price target on Navistar to $23 from $43, while the PT on Oshkosh goes to $58 from $66.</li><li>Navistar hit a 52-week low of $25.71 earlier in the session, while Oshkosh is now down 31% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415693\" data-linked=\"Goldman gloom hits Navistar and Oshkosh\" data-tweet=\"$NAV $NAV $OSK - Goldman gloom hits Navistar and Oshkosh https://seekingalpha.com/news/3415693-goldman-gloom-hits-navistar-and-oshkosh?source=tweet\" data-url=\"https://seekingalpha.com/news/3415693-goldman-gloom-hits-navistar-and-oshkosh\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415692\" data-ts=\"1544459266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRVO\" target=\"_blank\">QRVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415692-keybanc-downgrades-qorvo-to-sector-weight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc downgrades Qorvo to Sector Weight</a></h4><ul><li>KeyBanc <a href=\"https://www.streetinsider.com/Analyst+Comments/KeyBanc+Downgrades+Qorvo+Inc+%28QRVO%29+to+Sector+Weight/14904715.html\" target=\"_blank\">downgrades</a> Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-3.1%</font>) from Overweight to Sector Weight.</li><li>Analyst John Vinh cites further weakening of iPhone demand trends, weaker than expected smartphone demand in China, and indications Qualcomm is gaining market share with RF360.</li><li>Note that the KeyBanc downgrade happened before news broke of Qualcomm's preliminary patent victory over Apple in China.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415602-qualcomm-wins-preliminary-iphone-ban-china-update\" target=\"_blank\">Qualcomm wins preliminary iPhone ban in China (update)</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415692\" data-linked=\"KeyBanc downgrades Qorvo to Sector Weight\" data-tweet=\"$QRVO - KeyBanc downgrades Qorvo to Sector Weight https://seekingalpha.com/news/3415692-keybanc-downgrades-qorvo-to-sector-weight?source=tweet\" data-url=\"https://seekingalpha.com/news/3415692-keybanc-downgrades-qorvo-to-sector-weight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415685\" data-ts=\"1544458763\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415685-bp-pledges-to-consider-climate-resolution-activist-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BP pledges to consider climate resolution by activist investors</a></h4><ul><li>BP (<a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='red'>-2.1%</font>) says it will <a href=\"https://www.marketwatch.com/story/bp-to-consider-climate-resolution-for-2019-agm-2018-12-10\" target=\"_blank\">consider a climate resolution</a> proposed at its 2019 annual general meeting by activist investors who have previously sparked similar votes at meetings of Royal Dutch Shell.</li><li>The resolution <a href=\"https://seekingalpha.com/news/3415490-bp-faces-shareholder-challenge-climate-goals\" target=\"_blank\">filed by Dutch group Follow This</a> calls on BP to set and publish targets in line with goals set by the 2016 Paris Climate Agreement; the group says it also plans to file the motion for a fourth time with Shell.</li><li>Separately, Egypt's government says it has <a href=\"https://www.offshore-technology.com/news/egypt-approves-mubadala-bp-deals-for-stake-in-nour-block/\" target=\"_blank\">approved the sale of a 45% interest</a> in Eni\u2019s (<a href='https://seekingalpha.com/symbol/E' title='ENI S.p.A.'>E</a> <font color='red'>-0.6%</font>) Nour North Sinai Offshore concession in the eastern Mediterranean to BP and UAE-based Mubadala Petroleum.</li><li>BP will buy 25% and Mubadala 20% of Eni\u2019s stake, Egypt's petroleum ministry says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415685\" data-linked=\"BP pledges to consider climate resolution by activist investors\" data-tweet=\"$BP $BP $E - BP pledges to consider climate resolution by activist investors https://seekingalpha.com/news/3415685-bp-pledges-to-consider-climate-resolution-activist-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3415685-bp-pledges-to-consider-climate-resolution-activist-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415684\" data-ts=\"1544458645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415684-stocks-add-to-losses-brexit-in-question\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks add to losses with Brexit in question</a></h4><ul><li>A bit less than two hours into the session, modest early selling has ramped up, with the Dow <font color=\"red\">down 2%</font>, the S&amp;P <font color=\"red\">1.75%</font>, and Nasdaq <font color=\"red\">1.1%</font>.</li><li>The 10-year Treasury yield is off two basis points to 2.83%.</li><li>Slight declines in Europe have grown as well, with Theresa May's <a href=\"https://seekingalpha.com/news/3415669-uk-government-delays-parliament-vote-brexit-pound-slides\" target=\"_blank\">pulling of a Brexit vote</a> (and subsequent euro strength) a convenient excuse. The Stoxx 600 is <font color=\"red\">down 1.6%</font>. The FTSE is <font color=\"red\">off just 0.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VGK' title='Vanguard FTSE Europe ETF'>VGK</a>, <a href='https://seekingalpha.com/symbol/HEDJ' title='WisdomTree Europe Hedged Equity ETF'>HEDJ</a>, <a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>, <a href='https://seekingalpha.com/symbol/EZU' title='iShares MSCI Eurozone ETF'>EZU</a>, <a href='https://seekingalpha.com/symbol/IEV' title='iShares Europe ETF'>IEV</a>, <a href='https://seekingalpha.com/symbol/EPV' title='ProShares UltraShort FTSE Europe ETF'>EPV</a>, <a href='https://seekingalpha.com/symbol/IEUR' title='iShares Core MSCI Europe ETF'>IEUR</a>, <a href='https://seekingalpha.com/symbol/EURL' title='Direxion Daily FTSE Europe Bull 3x Shares ETF'>EURL</a>, <a href='https://seekingalpha.com/symbol/FEU' title='SPDR STOXX Europe 50 ETF'>FEU</a>, <a href='https://seekingalpha.com/symbol/DBEU' title='Deutsche X-trackers MSCI Europe Hedged Equity ETF'>DBEU</a>, <a href='https://seekingalpha.com/symbol/HEZU' title='iShares Currency Hedged MSCI EMU ETF'>HEZU</a>, <a href='https://seekingalpha.com/symbol/EEA' title='European Equity Fund'>EEA</a>, <a href='https://seekingalpha.com/symbol/FEEU' title='Barclays ETN+ FI Enhanced Europe 50 ETN'>FEEU</a>, <a href='https://seekingalpha.com/symbol/FEP' title='First Trust Europe AlphaDEX ETF'>FEP</a>, <a href='https://seekingalpha.com/symbol/UPV' title='ProShares Ultra FTSE Europe ETF'>UPV</a>, <a href='https://seekingalpha.com/symbol/ADRU' title='Invesco BLDRS Europe 100 ADR Index ETF'>ADRU</a>, <a href='https://seekingalpha.com/symbol/FEUZ' title='First Trust Eurozone AlphaDex ETF'>FEUZ</a>, <a href='https://seekingalpha.com/symbol/DBEZ' title='Deutsche X-trackers MSCI EMU Hedged Equity ETF'>DBEZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3415684\" data-linked=\"Stocks add to losses with Brexit in question\" data-tweet=\"$VGK $HEDJ $FEZ - Stocks add to losses with Brexit in question https://seekingalpha.com/news/3415684-stocks-add-to-losses-brexit-in-question?source=tweet\" data-url=\"https://seekingalpha.com/news/3415684-stocks-add-to-losses-brexit-in-question\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415682\" data-ts=\"1544458369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415682-micronminus-1_8-on-citi-estimate-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron -1.8% on Citi estimate cut</a></h4><ul><li>Citi maintains a Neutral rating and $40 price target on Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) but cuts the FY19 revenue and EPS estimates.</li><li>The firm expects lower DRAM and NAND ASPs due to overcapacity and inventory build. Citi expects NAND pricing to fall 45% in 2019 while DRAM falls 30% and doesn't see a bottom in pricing until Q2 at the earliest.</li><li>Analyst Peter Lee: \"It\u2019s time to get draconian.\"</li><li>Lee thinks Micron will forecast short of consensus when it reports earnings on December 18.</li><li>Source: Bloomberg First Word.</li><li>DRAM/NAND peers: Samsung (<a href='https://seekingalpha.com/symbol/SSNNF' title='Samsung Electronics Co., Ltd.'>OTC:SSNNF</a>, <a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>),<div>SK Hynix (<a href='https://seekingalpha.com/symbol/HXSCF' title='SK Hynix, Inc.'>OTC:HXSCF</a>, <a href='https://seekingalpha.com/symbol/HXSCL' title='SK Hynix, Inc.'>OTC:HXSCL</a>), Toshiba (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>), (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color='red'>-2.6%</font>), (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+0.3%</font>).  </div></li><li>Micron shares are <font color=\"red\">down 1.8%</font> to $34.68.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415682\" data-linked=\"Micron -1.8% on Citi estimate cut\" data-tweet=\"$MU $MU $SSNNF - Micron -1.8% on Citi estimate cut https://seekingalpha.com/news/3415682-micronminus-1_8-on-citi-estimate-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3415682-micronminus-1_8-on-citi-estimate-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>172&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415681\" data-ts=\"1544458121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOS\" target=\"_blank\">KTOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415681-kratosplus-6_2-goldman-upgrades-to-buy-on-rapid-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kratos +6.2% as Goldman upgrades to Buy on rapid growth</a></h4><ul>   <li>Drone maker Kratos Defense &amp; Security Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOS' title='Kratos Defense & Security Solutions, Inc.'>KTOS</a>) is <font color=\"green\">up 6.2%</font> after Goldman Sachs upgrades to Buy, citing very healthy revenue growth and a \"long list\" of programs.</li>    <li>\"We think revenue grows near 20% organically in both 2019 and 2020 ... then sustains double-digit growth through the middle of next decade,\" the firm says, noting growth is \"faster than everything else we cover.\" (h/t Bloomberg)</li>    <li>The firm raised its price target to $20 from $13, implying 38% further upside from today's pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415681\" data-linked=\"Kratos +6.2% as Goldman upgrades to Buy on rapid growth\" data-tweet=\"$KTOS - Kratos +6.2% as Goldman upgrades to Buy on rapid growth https://seekingalpha.com/news/3415681-kratosplus-6_2-goldman-upgrades-to-buy-on-rapid-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3415681-kratosplus-6_2-goldman-upgrades-to-buy-on-rapid-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415679\" data-ts=\"1544457837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INNT\" target=\"_blank\">INNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415679-iovance-biotherapeutics-and-axsome-therapeutics-among-healthcare-gainers-axovant-sciences\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iovance Biotherapeutics and Axsome Therapeutics among Healthcare gainers; Axovant Sciences among losers</a></h4><ul><li><b>Gainers: </b>Innovate Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a>) <font color=\"green\">+14%</font>. Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a>) <font color=\"green\">+13%</font>. Kiniksa Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KNSA' title='Kiniksa Pharmaceuticals'>KNSA</a>) <font color=\"green\">+7%</font>. Pfenex (NYSEMKT:<a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a>) <font color=\"green\">+6%</font>. Iovance Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Tivity Health (NASDAQ:<a href='https://seekingalpha.com/symbol/TVTY' title='Tivity Health, Inc.'>TVTY</a>) <font color=\"red\">-33%</font>. MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) <font color=\"red\">-28%</font>. Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) <font color=\"red\">-25%</font>. Gritstone Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/GRTS' title='Gritstone Oncology'>GRTS</a>) <font color=\"red\">-14%</font>. Adial Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADIL' title='ADial Pharmaceuticals, Inc'>ADIL</a>) <font color=\"red\">-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415679\" data-linked=\"Iovance Biotherapeutics and Axsome Therapeutics among Healthcare gainers; Axovant Sciences among losers\" data-tweet=\"$INNT $INNT $AXSM - Iovance Biotherapeutics and Axsome Therapeutics among Healthcare gainers; Axovant Sciences among losers https://seekingalpha.com/news/3415679-iovance-biotherapeutics-and-axsome-therapeutics-among-healthcare-gainers-axovant-sciences?source=tweet\" data-url=\"https://seekingalpha.com/news/3415679-iovance-biotherapeutics-and-axsome-therapeutics-among-healthcare-gainers-axovant-sciences\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415675\" data-ts=\"1544457666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNLO\" target=\"_blank\">MNLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415675-menlos-serlopitant-successful-in-mid-stage-pruritis-study-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Menlo&#39;s serlopitant successful in mid-stage pruritis study; shares up 1%</a></h4><ul><li>Thinly traded micro cap Menlo Therapeutics (<a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a> <font color=\"green\">+1.4%</font>) is up on light volume following its <a href=\"https://seekingalpha.com/pr/17352661-menlo-therapeutics-successful-phase-2-clinical-trial-serlopitant-demonstrates-reduction\" target=\"_blank\">announcement </a>of positive results from a 204-subject <a href=\"https://clinicaltrials.gov/ct2/show/NCT03343639?spons=menlo&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating MTI-109 (serlopitant), branded as PSORIXA, for the treatment of pruritis (itchy skin) in psoriasis patients.</li><li>The study met the primary endpoint of a statistically significant proportion of patients experiencing at least a four-point reduction in a scale called WI-NRS. Specifically, 33% of patients met the criterion compared to 21% for placebo (p=0.028).</li><li>The trial also met the secondary endpoint of WI-NRS responder rate at week 4 (21% vs. 11%; p=0.039).</li><li>The safety profile of MTI-109 was similar to control.</li><li>The company plans to meet with the FDA in H1 2019 to discuss the data and clarify the parameters of Phase 3 studies, expected to start soon thereafter.</li><li>Enrollment is underway in two Phase 3 trials evaluating serlopitant for the treatment of pruritis in patients with prurigo nodularis. Topline data are expected in Q1 2020.</li><li>Enrollment should start in the next few weeks in a Phase 2 study in idiopathic (unknown cause) pruritis.</li><li>Menlo licensed serlopitant, a small molecule neurokinin 1 receptor (NK1) antagonist, from Merck in 2012.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415675\" data-linked=\"Menlo&#39;s serlopitant successful in mid-stage pruritis study; shares up 1%\" data-tweet=\"$MNLO - Menlo&#39;s serlopitant successful in mid-stage pruritis study; shares up 1% https://seekingalpha.com/news/3415675-menlos-serlopitant-successful-in-mid-stage-pruritis-study-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3415675-menlos-serlopitant-successful-in-mid-stage-pruritis-study-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415677\" data-ts=\"1544457652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415677-tsmc-and-umc-report-revenue-drops-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSMC and UMC report revenue drops in November</a></h4><ul><li>TSMC (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a> <font color='red'>-0.8%</font>) and United Microelectronics (<a href='https://seekingalpha.com/symbol/UMC' title='United Microelectronics Corporation'>UMC</a> <font color='red'>-1.1%</font>) <a href=\"https://www.digitimes.com/news/a20181209VL201.html\" target=\"_blank\">report</a> sequential consolidated revenue decreases for November.</li><li>TSMC reported $3.19B in revenue, up nearly 6% Y/Y But down 3% Q/Q. The company previously forecasted Q4 revenue from $9.35B to $9.45B, which analysts expect TSMC to meet despite seeing another Q/Q decline in December on slower shipments to a significant smartphone client. That client is thought to be Apple.</li><li>UMC's November revenue dropped 5% Y/Y to NT$11.55B, down 8% Q/Q. UMC expects wafer shipments and ASPs to fall 4% to 5% Q/Q in the fourth quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415677\" data-linked=\"TSMC and UMC report revenue drops in November\" data-tweet=\"$TSM $TSM $UMC - TSMC and UMC report revenue drops in November https://seekingalpha.com/news/3415677-tsmc-and-umc-report-revenue-drops-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3415677-tsmc-and-umc-report-revenue-drops-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415674\" data-ts=\"1544457151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415674-goodyear-tire-rubber-exits-venezuela\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber exits Venezuela</a></h4><ul> <li>Goodyear Tire &amp; Rubber (NYSE:<a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a>) has officially <a href=\"https://www.reuters.com/article/us-goodyear-venezuela/goodyear-permanently-ceases-venezuela-operations-union-leader-idUSKBN1O91R5\" target=\"_blank\">shut down</a> its operations in Venezuela, according to Reuters.</li> <li>Union leaders in the region confirm that there is no activity at Goodyear de Venezuela's plant.</li> <li>Goodyear is the just the latest of a long string of multinationals to exit Venezuela.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415674\" data-linked=\"Goodyear Tire &amp; Rubber exits Venezuela\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber exits Venezuela https://seekingalpha.com/news/3415674-goodyear-tire-rubber-exits-venezuela?source=tweet\" data-url=\"https://seekingalpha.com/news/3415674-goodyear-tire-rubber-exits-venezuela\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415668\" data-ts=\"1544456835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZNGA\" target=\"_blank\">ZNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415668-zyngaplus-2_2-jefferies-sees-positives-in-pipeline-hq-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynga +2.2% as Jefferies sees positives in pipeline, HQ sale</a></h4><ul>   <li>Zynga (NASDAQ:<a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a>) is <font color=\"green\">up 2.2%</font> after some positivity from Jefferies coming out of management meetings.</li>    <li>Analyst Timothy O'Shea says eight new games are expected by 2020, shoring up the pipeline, and the potential sale of its San Francisco headquarters could bring $600M, which could fuel more M&amp;A and buybacks. (h/t Bloomberg)</li>    <li>Zynga had bought the elaborate headquarters space in 2012 for $228M (at which point it took up 65% of the space), and has considered a sale at various points over the past couple of years.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3140516-zynga-4_1-percent-mulls-drawing-big-gain-hq-sale\" target=\"_blank\">Zynga up 4.1% as it mulls drawing big gain on HQ sale</a> (Feb. 25 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415668\" data-linked=\"Zynga +2.2% as Jefferies sees positives in pipeline, HQ sale\" data-tweet=\"$ZNGA - Zynga +2.2% as Jefferies sees positives in pipeline, HQ sale https://seekingalpha.com/news/3415668-zyngaplus-2_2-jefferies-sees-positives-in-pipeline-hq-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3415668-zyngaplus-2_2-jefferies-sees-positives-in-pipeline-hq-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415666\" data-ts=\"1544456447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415666-apple-suppliers-dip-on-chinas-iphone-ban\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple suppliers dip on China&#39;s iPhone ban</a></h4><ul><li>Some Apple suppliers are dropping following the news that Qualcomm won a preliminary ban on certain iPhones in China.</li><li>Among the movers: (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-1.1%</font>), (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-1.6%</font>), (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-2.4%</font>), (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-0.7%</font>), (<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a> <font color='red'>-0.4%</font>), (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a> <font color='red'>-0.8%</font>).</li><li>Note that Lumentum, Qorvo, and Cirrus have recently cut their guidance on weak smartphone demand or lowered orders from a large customer.</li><li>Qualcomm rival Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) is <font color=\"green\">up 1%</font> to $46.69.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415602-qualcomm-wins-preliminary-iphone-ban-china-update\" target=\"_blank\">Qualcomm wins preliminary iPhone ban in China (update)</a> (Dec. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415666\" data-linked=\"Apple suppliers dip on China&#39;s iPhone ban\" data-tweet=\"$LITE $LITE $SWKS - Apple suppliers dip on China&#39;s iPhone ban https://seekingalpha.com/news/3415666-apple-suppliers-dip-on-chinas-iphone-ban?source=tweet\" data-url=\"https://seekingalpha.com/news/3415666-apple-suppliers-dip-on-chinas-iphone-ban\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415664\" data-ts=\"1544456267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415664-glu-mobileplus-7_3-cowen-names-2019-best-idea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile +7.3% as Cowen names it 2019 best idea</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) is <font color=\"green\">up 7.3%</font> after being named the best idea for 2019 by Cowen.</li>    <li>The company's achieved a \"significant\" turn-around under new management, and the excellent execution comes with an exciting pipeline and a still \"reasonable\" valuation, analyst Doug Creutz says. Fiscal 2019 guidance doesn't include contribution from three new game launches to come (including a Disney/Pixar game), and profitability should continue with those contributions combined with improvement in existing franchises. (h/t Bloomberg)</li>    <li>The firm reiterated its Outperform rating and Creutz boosted his price target to $9.50 from $8, implying 25% upside from current pricing.</li>    <li>The stock is <font color=\"green\">up 94.5%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415664\" data-linked=\"Glu Mobile +7.3% as Cowen names it 2019 best idea\" data-tweet=\"$GLUU - Glu Mobile +7.3% as Cowen names it 2019 best idea https://seekingalpha.com/news/3415664-glu-mobileplus-7_3-cowen-names-2019-best-idea?source=tweet\" data-url=\"https://seekingalpha.com/news/3415664-glu-mobileplus-7_3-cowen-names-2019-best-idea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415661\" data-ts=\"1544455989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415661-ligand-pharma-up-1-on-advancement-of-lasofoxifene-licensee-sermonix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ligand Pharma up 1% on advancement of lasofoxifene by licensee Sermonix</a></h4><ul><li>Ligand Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a> <font color=\"green\">+0.6%</font>) is up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17353176-sermonix-announces-fda-acceptance-ind-application-will-begin-phase-2-trial-lasofoxifene\" target=\"_blank\">announcement </a>that the FDA has accepted the IND from lasofoxifene licensee Sermonix Pharmaceuticals LLC.</li><li>A Phase 2 study comparing oral lasofoxifene to intramuscular injection-administered fulvestrant [AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color=\"green\">+0.6%</font>) <a href=\"https://www.faslodex.com/metastatic-breast-cancer/faslodex-ibrance-clinical-trial.html?source=FAS_D_C_14&amp;umedium=CPC&amp;uadpub=Google&amp;ucampaign=FaslodexDTCBranded_General&amp;ucreative=Branded_Alone_EX&amp;uplace=fulvestrant&amp;cmpid=1\" target=\"_blank\">Faslodex</a>] in postmenopausal women with locally advanced/metastatic ER+/HER2- breast cancer with an ESR1 mutation should launch next quarter.</li><li>Lasofoxifene is a nonsteroidal estrogen receptor modulator.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415661\" data-linked=\"Ligand Pharma up 1% on advancement of lasofoxifene by licensee Sermonix\" data-tweet=\"$LGND $LGND $AZN - Ligand Pharma up 1% on advancement of lasofoxifene by licensee Sermonix https://seekingalpha.com/news/3415661-ligand-pharma-up-1-on-advancement-of-lasofoxifene-licensee-sermonix?source=tweet\" data-url=\"https://seekingalpha.com/news/3415661-ligand-pharma-up-1-on-advancement-of-lasofoxifene-licensee-sermonix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415647\" data-ts=\"1544454572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LASR\" target=\"_blank\">LASR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415647-needham-trims-nlight-target-to-upside-lasrplus-4_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham trims nLIGHT target to upside; LASR +4.5%</a></h4><ul><li>Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Nlight+%28LASR%29+PT+Lowered+to+%2427+at+Needham+%26+Company/14905535.html\" target=\"_blank\">maintains </a>a Buy rating on nLIGHT (NASDAQ:<a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a>) but drops the target from $29 to $27.</li><li>Analyst James Ricchiuti cites meetings with management last week where he came away confident that LASR can meet Q4 expectations, but the firm trims 1H estimates on the uncertain macro environment in China.</li><li>LASR shares are <font color=\"green\">up 4.5%</font> to $19.97.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415647\" data-linked=\"Needham trims nLIGHT target to upside; LASR +4.5%\" data-tweet=\"$LASR - Needham trims nLIGHT target to upside; LASR +4.5% https://seekingalpha.com/news/3415647-needham-trims-nlight-target-to-upside-lasrplus-4_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3415647-needham-trims-nlight-target-to-upside-lasrplus-4_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415639\" data-ts=\"1544453733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFNX\" target=\"_blank\">PFNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415639-pfenex-files-u-s-marketing-application-for-generic-forteo-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pfenex files U.S. marketing application for generic Forteo; shares up 5%</a></h4><ul><li>Thinly traded micro cap Pfenex (<a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a> <font color=\"green\">+5.2%</font>) is up on light volume in early trade following its <a href=\"https://seekingalpha.com/pr/17352784-pfenex-submits-new-drug-application-u-s-fda-seeking-approval-pf708-treatment-osteoporosis\" target=\"_blank\">announcement </a>that it has submitted its U.S. marketing application seeking approval for PF708, a generic version of Eli Lilly's (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"red\">-0.9%</font>) osteoporosis med Forteo (teriparatide) which generated $1,138.5M in sales through the first three quarters of this year.</li><li>The company says market launch could happen as early as Q4 2019 if all goes according to plan. Alvogen will commercialize.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363141-pfenex-licenses-lead-candidate-pf708-u-s-27_5m-plus-cut-gross-profit-shares-5-percent-hours\" target=\"_blank\">Pfenex out-licenses lead candidate PF708 in U.S. for $27.5M plus cut of gross profit; shares up 5% after hours</a> (June 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415639\" data-linked=\"Pfenex files U.S. marketing application for generic Forteo; shares up 5%\" data-tweet=\"$PFNX $PFNX $LLY - Pfenex files U.S. marketing application for generic Forteo; shares up 5% https://seekingalpha.com/news/3415639-pfenex-files-u-s-marketing-application-for-generic-forteo-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3415639-pfenex-files-u-s-marketing-application-for-generic-forteo-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415638\" data-ts=\"1544453679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415638-markets-give-way-in-early-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Markets give way in early action</a></h4><ul><li>Futures were in the green headed into the open, but stocks are slipping in the session's first thirty minutes. The S&amp;P 500 is <font color=\"red\">off 0.8%</font>, and the Dow <font color=\"red\">0.95%</font>. The Nasdaq is <font color=\"red\">lower by 0.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415638\" data-linked=\"Markets give way in early action\" data-tweet=\"Markets give way in early action https://seekingalpha.com/news/3415638-markets-give-way-in-early-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3415638-markets-give-way-in-early-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415637\" data-ts=\"1544453610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415637-lumentum-completes-oclaro-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumentum completes Oclaro acquisition</a></h4><ul><li>Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='green'>+0.6%</font>) <a href=\"https://seekingalpha.com/pr/17353098-lumentum-announces-completion-oclaro-acquisition\" target=\"_blank\">completes</a> its Oclaro (<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) acquisition, which means Oclaro will stop trading today.</li><li>Oclaro stockholders will receive $5.60 in cash and 0.0636 of a share of Lumentum common stock for each share of Oclaro common stock. </li><li>Lumentum anticipates achieving an estimated $60M in synergies in the next 12 to 24 months. </li></ul><div class=\"tiny-share-widget\" data-id=\"3415637\" data-linked=\"Lumentum completes Oclaro acquisition\" data-tweet=\"$LITE $LITE $OCLR - Lumentum completes Oclaro acquisition https://seekingalpha.com/news/3415637-lumentum-completes-oclaro-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3415637-lumentum-completes-oclaro-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415634\" data-ts=\"1544453511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMNX\" target=\"_blank\">LMNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415634-luminex-down-4-on-off-wall-street-caution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Luminex down 4% on Off Wall Street caution</a></h4><ul><li>According to Bloomberg, Off Wall Street is out with a cautious note this morning on Luminex (<a href='https://seekingalpha.com/symbol/LMNX' title='Luminex Corporation'>LMNX</a> <font color=\"red\">-4.4%</font>).</li><li>Update: Some details <a href=\"https://www.streetinsider.com/stock_lookup.php?LookUp=Get+Quote&amp;q=lmnx\" target=\"_blank\">via StreetInsider</a> ... OWS's price target of $17.05 is <font color=\"red\">40% lower</font> than Friday's close. Troubling royalty revenue growth is being masked by revenue recognition changes, says OWS.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415634\" data-linked=\"Luminex down 4% on Off Wall Street caution\" data-tweet=\"$LMNX - Luminex down 4% on Off Wall Street caution https://seekingalpha.com/news/3415634-luminex-down-4-on-off-wall-street-caution?source=tweet\" data-url=\"https://seekingalpha.com/news/3415634-luminex-down-4-on-off-wall-street-caution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415568\" data-ts=\"1544452815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXON\" target=\"_blank\">AXON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415568-axovants-nelotanserin-flunks-mid-stage-study-shares-down-27-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant&#39;s nelotanserin flunks mid-stage study, shares down 27% premarket</a></h4><ul><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) is down <font color=\"red\">27%</font> premarket on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/17352658-axovant-reports-results-exploratory-phase-2-clinical-study-nelotanserin-lewy-body-dementia\" target=\"_blank\">announcement </a>that a 34-subject Phase 2 pilot study evaluating nelotanserin for the the treatment of REM sleep behavior disorder &#40;RBD&#41; in patients with Lewy body dementia failed to achieve the primary endpoint of a statistically significant reduction in RBD events.</li><li>The company will not pursue further development, opting instead to concentrate on its gene therapies.</li><li><strong>Update</strong>: The product was being supplied by Arena Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a> <font color=\"green\">+0.6%</font>) under a 2015 agreement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415568\" data-linked=\"Axovant&#39;s nelotanserin flunks mid-stage study, shares down 27% premarket\" data-tweet=\"$AXON $AXON-OLD $ARNA - Axovant&#39;s nelotanserin flunks mid-stage study, shares down 27% premarket https://seekingalpha.com/news/3415568-axovants-nelotanserin-flunks-mid-stage-study-shares-down-27-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415568-axovants-nelotanserin-flunks-mid-stage-study-shares-down-27-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415627\" data-ts=\"1544452793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415627-five-belowplus-2-after-loop-capital-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below +2% after Loop Capital upgrade</a></h4><ul> <li>Five Below (<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color='green'>+2.3%</font>) rallies after Loop Capital upgrades the retailer to a Buy rating.</li> <li>The firm sets a price target of $120 on FIVE to rep +25% upside potential.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3415627\" data-linked=\"Five Below +2% after Loop Capital upgrade\" data-tweet=\"$FIVE - Five Below +2% after Loop Capital upgrade https://seekingalpha.com/news/3415627-five-belowplus-2-after-loop-capital-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3415627-five-belowplus-2-after-loop-capital-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415626\" data-ts=\"1544452786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XNET\" target=\"_blank\">XNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415626-xunleiplus-2_7-amid-iot-partnership-china-mobile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xunlei +2.7% amid IoT partnership with China Mobile</a></h4><ul>   <li>Xunlei Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>) is <font color=\"green\">up 2.7%</font> after announcing a strategic <a href=\"https://seekingalpha.com/pr/17352706-xunlei-forges-strategic-partnership-china-mobile-iot-develop-blockchain-iot-applications\" target=\"_blank\">Internet of Things/blockchain partnership</a> with China Mobile (<a href=\"http://seekingalpha.com/symbol/CHL\" target=\"_blank\">CHL</a> <font color=\"red\">-0.7%</font>).</li>    <li>Xunlei is teaming with wholly owned subsidiary China Mobile IoT Co. Ltd. to leverage blockchain technology to develop industry solutions in the deal.</li>    <li>That will mean joint investment in R&amp;D as well as sharing market intelligence, providing traffic support and strengthening product operations.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415626\" data-linked=\"Xunlei +2.7% amid IoT partnership with China Mobile\" data-tweet=\"$XNET $XNET $CHL - Xunlei +2.7% amid IoT partnership with China Mobile https://seekingalpha.com/news/3415626-xunleiplus-2_7-amid-iot-partnership-china-mobile?source=tweet\" data-url=\"https://seekingalpha.com/news/3415626-xunleiplus-2_7-amid-iot-partnership-china-mobile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415612\" data-ts=\"1544451952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVN\" target=\"_blank\">TRVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415612-trevena-promotes-robert-t-yoder-to-senior-vice-president-and-chief-business-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trevena promotes Robert T. Yoder to Senior Vice President and Chief Business Officer</a></h4><ul> <li>Trevena (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>) <a href=\"https://seekingalpha.com/pr/17352653-trevena-promotes-robert-t-yoder-senior-vice-president-chief-business-officer\" target=\"_blank\">promotes</a> Robert T. Yoder from Vice President Commercial Operations and Sales to the newly created position of Senior Vice President and Chief Business Officer, effective immediately.</li>     <li>Mr. Yoder joined Trevena as Vice President of Commercial Operations and Sales in June 2018. Prior to this, he served as Senior Vice President and Head of Global Commercial Operations, Alliance Management and IT at Orexigen Therapeutics, from March 2015 through June 2018.</li><li>Shares are up <font color=\"green\">4%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3415612\" data-linked=\"Trevena promotes Robert T. Yoder to Senior Vice President and Chief Business Officer\" data-tweet=\"$TRVN - Trevena promotes Robert T. Yoder to Senior Vice President and Chief Business Officer https://seekingalpha.com/news/3415612-trevena-promotes-robert-t-yoder-to-senior-vice-president-and-chief-business-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3415612-trevena-promotes-robert-t-yoder-to-senior-vice-president-and-chief-business-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415608\" data-ts=\"1544451502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERI\" target=\"_blank\">VERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415608-veritoneplus-44-apis-raises-buyout-offer-to-82-premium\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veritone +44% as Apis raises buyout offer to 82% premium</a></h4><ul>   <li>Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>) is <font color=\"green\">up 43.9%</font> premarket after bidder Apis Capital Management has <a href=\"https://seekingalpha.com/filing/4264072\" target=\"_blank\">raised an all-cash offer</a> to purchase the company to $10.26/share.</li>    <li>That marks a 93% premium to the closing price on Dec. 4, the date of an initial private written proposal.</li>    <li>Apis <a href=\"https://seekingalpha.com/filing/4264073\" target=\"_blank\">reports a 5.03% stake</a> in the company in an SEC filing.</li>    <li>Shares had closed Friday at $5.63.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415608\" data-linked=\"Veritone +44% as Apis raises buyout offer to 82% premium\" data-tweet=\"$VERI - Veritone +44% as Apis raises buyout offer to 82% premium https://seekingalpha.com/news/3415608-veritoneplus-44-apis-raises-buyout-offer-to-82-premium?source=tweet\" data-url=\"https://seekingalpha.com/news/3415608-veritoneplus-44-apis-raises-buyout-offer-to-82-premium\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415605\" data-ts=\"1544451101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRI\" target=\"_blank\">NTRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415605-healthcare-and-m-stocks-up-in-premarket-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare and M&amp;A stocks up in premarket trade</a></h4><ul><li>Nutrisystem (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a>) <font color=\"green\">+31%</font> on cash and stock <a href=\"https://seekingalpha.com/news/3415576-investors-size-tivity-health-nutrisystem-deal\" target=\"_blank\">offer</a> from Tivity Health.</li><li>Mitek Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems Inc.'>MITK</a>) <font color=\"green\">+16%</font> as ASG <a href=\"https://seekingalpha.com/news/3415591-mitek-plus-17-percent-asg-boosts-offer\" target=\"_blank\">boosts</a> offer.</li><li>Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a>) <font color=\"green\">+17%</font> as Phase 2/3 study of Axsome's AXS-05 in AD-related agitation to <a href=\"https://seekingalpha.com/news/3415592-phase-2-3-study-axsomes-axsminus-05-ad-related-agitation-continue-shares-23-percent-premarket\" target=\"_blank\">continue</a>.</li><li>Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"green\">+14%</font>.</li><li>Ekso Bionics Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3415577-ekso-secures-purchase-orders-eksovest\" target=\"_blank\">purchase orders</a> for EksoVest.</li><li>Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+11%</font>.</li><li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) <font color=\"green\">+11%</font> as ganaxolone <a href=\"https://seekingalpha.com/news/3415555-marinus-pharmas-ganaxolone-shows-positive-action-mid-stage-postpartum-depression-studies\" target=\"_blank\">shows positive action</a> in mid-stage postpartum depression studies.</li><li>Achaogen (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/pr/17352802-achaogen-announces-fda-clearance-launch-thermo-scientific-qms-plazomicin-immunoassay\" target=\"_blank\">receiving</a> FDA clearance for the Thermo Scientific QMS Plazomicin Immunoassa.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415605\" data-linked=\"Healthcare and M&amp;A stocks up in premarket trade\" data-tweet=\"$NTRI $NTRI $MITK - Healthcare and M&amp;A stocks up in premarket trade https://seekingalpha.com/news/3415605-healthcare-and-m-stocks-up-in-premarket-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3415605-healthcare-and-m-stocks-up-in-premarket-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415604\" data-ts=\"1544451045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXON\" target=\"_blank\">AXON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415604-healthcare-stocks-down-in-premarket-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare stocks down in premarket trade</a></h4><ul><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) <font color=\"red\">-23%</font> after nelotanserin <a href=\"https://seekingalpha.com/news/3415568-axovants-nelotanserin-flunks-mid-stage-study-shares-27-percent-premarket\" target=\"_blank\">flunks</a> mid-stage study.</li><li>Tivity Health (NASDAQ:<a href='https://seekingalpha.com/symbol/TVTY' title='Tivity Health, Inc.'>TVTY</a>) <font color=\"red\">-18%</font> on <a href=\"https://seekingalpha.com/news/3415576-investors-size-tivity-health-nutrisystem-deal\" target=\"_blank\">acquiring</a> Nutrisystem in a cash and stock deal.</li><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415604\" data-linked=\"Healthcare stocks down in premarket trade\" data-tweet=\"$AXON $AXON-OLD $TVTY - Healthcare stocks down in premarket trade https://seekingalpha.com/news/3415604-healthcare-stocks-down-in-premarket-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3415604-healthcare-stocks-down-in-premarket-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415602\" data-ts=\"1544450742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415602-qualcomm-wins-preliminary-iphone-ban-in-china-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm wins preliminary iPhone ban in China (update)</a></h4><ul><li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://www.reuters.com/article/us-qualcomm-apple/qualcomm-wins-import-ban-against-several-apple-iphones-in-china-idUSKBN1O91LD?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FbusinessNews+%28Business+News%29\" target=\"_blank\">says </a>it has won a preliminary order from a Chinese court banning imports and sales of several Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhone models in the region.</li><li>The Fuzhou Intermediate People\u2019s Court order affects the iPhone 6S to iPhone X, which the court found violated two of Qualcomm's software-related patents for photograph resizing and touch screen application management.</li><li>Apple could update the software to remove the infringing features and continue selling the phones.</li><li>Earlier this year, the same court banned the import of some Micron chips.</li><li>In Citi's Apple target cut this morning, the firm cited Apple's exposure to China, which accounts for about 18% of total sales.</li><li>Apple shares are <font color=\"red\">down 1.3%</font> premarket. Qualcomm shares are <font color=\"green\">up 2.2%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3415550-citi-125-bear-case-apple\" target=\"_blank\">Citi has $125 bear case for Apple</a> (Dec. 10)</li><li>Update: Apple tells CNBC's David Faber that all iPhone models remain available to customers in China.</li><li>Apple: \"Qualcomm's effort to ban our products is another desperate move by a company whose illegal practices are under investigation by regulators around the world. All iPhone models remain available for our customers in China. Qualcomm is asserting three patents they had never raised before, including one which has already been invalidated. We will pursue all our legal options through the courts.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3415602\" data-linked=\"Qualcomm wins preliminary iPhone ban in China (update)\" data-tweet=\"$QCOM $QCOM $AAPL - Qualcomm wins preliminary iPhone ban in China (update) https://seekingalpha.com/news/3415602-qualcomm-wins-preliminary-iphone-ban-in-china-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3415602-qualcomm-wins-preliminary-iphone-ban-in-china-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>171&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415599\" data-ts=\"1544450563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415599-qudian-says-chao-zhu-resigns-from-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qudian says Chao Zhu resigns from board</a></h4><ul><li>Qudian says Chao Zhu<a href=\"https://seekingalpha.com/pr/17352632-qudian-inc-announces-changes-board-directors\" target=\"_blank\"> resigns</a> from its board, and, as a result, the board will achieve majority independence.</li><li>Rong Shengwen, an independent director, will fill the compensation committee opening resulting from Zhu's resignation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3411538-qudian-plus-11-percent-q3-beats-guidance-reaffirmed\" target=\"_blank\">Qudian +11% after Q3 beats, guidance reaffirmed</a> (Nov. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415599\" data-linked=\"Qudian says Chao Zhu resigns from board\" data-tweet=\"Qudian says Chao Zhu resigns from board https://seekingalpha.com/news/3415599-qudian-says-chao-zhu-resigns-from-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3415599-qudian-says-chao-zhu-resigns-from-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415598\" data-ts=\"1544450556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415598-biocept-files-for-stock-offering-shares-down-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biocept files for stock offering; shares down 2% premarket</a></h4><ul><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) slips <font color=\"red\">2%</font> premarket on light volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1044378/000156459018030702/bioc-s1a.htm\" target=\"_blank\">prospectus </a>for a public offering of ~9.7M shares of common stock and warrants to purchase up to the same number of shares at an assumed combined price of $1.03, Friday's close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3415598\" data-linked=\"Biocept files for stock offering; shares down 2% premarket\" data-tweet=\"$BIOC - Biocept files for stock offering; shares down 2% premarket https://seekingalpha.com/news/3415598-biocept-files-for-stock-offering-shares-down-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3415598-biocept-files-for-stock-offering-shares-down-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415595\" data-ts=\"1544450063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415595-inpixonplus-16-on-patent-application-acceptance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inpixon +16% on patent application acceptance</a></h4><ul><li>Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"green\">gains 16%</font> premarket on announcing it received notice from the U.S. Patent and Trademark Office allowing its application for techniques to dynamically adapt network policies for mobile devices by accessing context-based values to allocate (or restrict) capabilities on mobile devices or the network.  The tech appears in Inpixon's Indoor Positioning Analytics Platform, which users RF sensors to identify the indoor location of a wireless device then leverage an AI-powered data analytics engine to reveal intelligence like visitor counts and customer behavior patterns. </li></ul><div class=\"tiny-share-widget\" data-id=\"3415595\" data-linked=\"Inpixon +16% on patent application acceptance\" data-tweet=\"$INPX - Inpixon +16% on patent application acceptance https://seekingalpha.com/news/3415595-inpixonplus-16-on-patent-application-acceptance?source=tweet\" data-url=\"https://seekingalpha.com/news/3415595-inpixonplus-16-on-patent-application-acceptance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415594\" data-ts=\"1544450058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415594-papa-jonhs-founder-hires-financial-advisor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa Jonh&#39;s founder hires financial advisor</a></h4><ul> <li>Papa John's International (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) founder John Schnatter has engaged a financial advisor to assist him in reviewing the financial prospects of the company and in assessing alternatives for increasing shareholder value, according to a SEC filing.</li> <li>While analysts have warned in the past that Schnatter's involvement with the chain could continue to harm the brand, the founder appears to be pressing on.</li><li><a href=\"https://seekingalpha.com/filing/4263600\" target=\"_blank\">SEC Form 8-K</a></li> <li>PZZA <font color=\"green\">+0.91%</font> premarket to $45.49.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3415594\" data-linked=\"Papa Jonh&#39;s founder hires financial advisor\" data-tweet=\"$PZZA - Papa Jonh&#39;s founder hires financial advisor https://seekingalpha.com/news/3415594-papa-jonhs-founder-hires-financial-advisor?source=tweet\" data-url=\"https://seekingalpha.com/news/3415594-papa-jonhs-founder-hires-financial-advisor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3415593\" data-ts=\"1544450004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RF\" target=\"_blank\">RF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3415593-keycorp-regions-cut-nomura-on-credit-loan-growth-uncertainty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyCorp, Regions cut by Nomura on credit, loan growth uncertainty</a></h4><ul><li>Nomura Instinet analyst Bill Carcache downgrades Regions Financial (NYSE:<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a>) and KeyCorp (NYSE:<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a>) as he sees recent growth in commercial and industrial lending as \"low quality,\" which is likely to increase losses.</li><li>Regions -<font color=\"red\">0.5%</font>, KeyCorp<font color=\"red\"> -1.7% </font>in premarket trading.</li><li>Cuts both banks to reduce from neutral.</li><li>Carcache notes bank loan portfolios would be shrinking if C&amp;I weren't increasing.</li><li>Banks are taking share in C&amp;I lending as underwriting standards ease and demand weakens.</li><li>Also sees Fifth Third Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a>) and Huntington Bancshares (NASDAQ:<a href='https://seekingalpha.com/symbol/HBAN' title='Huntington Bancshares Incorporated'>HBAN</a>) facing challenges from slowing C&amp;I loan growth and higher net charge-offs.</li><li>HBAN <font color=\"red\">-1.3% </font>in premarket trading.</li><li>Source: Bloomberg First Word.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3412008-regions-financial-plus-1_5-percent-jpmorgan-upgrades-loan-growth-nim\" target=\"_blank\">Regions Financial +1.5% after JPMorgan upgrades on loan growth, NIM</a> (Nov. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3415593\" data-linked=\"KeyCorp, Regions cut by Nomura on credit, loan growth uncertainty\" data-tweet=\"$RF $RF $KEY - KeyCorp, Regions cut by Nomura on credit, loan growth uncertainty https://seekingalpha.com/news/3415593-keycorp-regions-cut-nomura-on-credit-loan-growth-uncertainty?source=tweet\" data-url=\"https://seekingalpha.com/news/3415593-keycorp-regions-cut-nomura-on-credit-loan-growth-uncertainty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}